Use of hypnotics and sedatives

RX_N05C

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N05C 1 out of 7 registries used, show all original rules.	88900
4. Check minimum number of events Min. number of events 3	88900
5. Include endpoints None	88900
6. Filter based on genotype QC (FinnGen only)	88900

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	RX_N05C
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N05C
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of hypnotics and sedatives based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	791068	467501	316347
Only index persons	649689	398173	251516
Unadjusted period prevalence (%)
Whole population	11.52	13.39	8.84
Only index persons	12.69	14.64	9.60
Median age at first event (years)
Whole population	57.02	58.33	54.85
Only index persons	54.22	55.71	51.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	88900	52800	36100
Unadjusted period prevalence (%)	17.15	18.00	15.91
Median age at first event (years)	52.19	50.20	55.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
26415: Matched controls
181116

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

5.8

323.0

4063

5495

N05AD01

ATC

haloperidol; systemic

8.0

323.0

1087

965

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.0

323.0

927

940

AA1AD

NOMESCO Finland

CT of head and brain

2.3

323.0

4700

15432

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

323.0

5887

22188

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

323.0

8834

37741

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

7.9

323.0

884

788

F51

ICD-10 Finland

Nonorganic sleep disorders

4.1

323.0

1446

2511

N05AA01

ATC

chlorpromazine; systemic, rectal

10.2

323.0

765

526

N06AA06

ATC

trimipramine; systemic

12.7

323.0

1166

657

N05CD02

ATC

nitrazepam; oral

49.6

323.0

483

N06AX12

ATC

bupropion; oral

4.4

323.0

3414

5937

N05AB03

ATC

perphenazine; systemic, rectal

6.9

323.0

1696

1791

N05CD08

ATC

midazolam; nasal, systemic

21.7

323.0

780

254

N03AX09

ATC

lamotrigine; oral

6.0

323.0

2883

3627

N05AF03

ATC

chlorprothixene; systemic

11.3

323.0

1807

1169

N05AH03

ATC

olanzapine; systemic

7.0

323.0

3737

4161

N04AA02

ATC

biperiden; systemic

8.6

323.0

941

772

N05BA04

ATC

oxazepam; oral

6.5

323.0

11172

18373

N06AB05

ATC

paroxetine; oral

4.4

323.0

2688

4552

N06AB04

ATC

citalopram; systemic

4.7

323.0

8777

17176

P76

ICPC

Depressive disorder

3.2

323.0

2424

5533

N06AX22

ATC

agomelatine; oral

5.7

323.0

1099

1377

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

323.0

4655

16279

N05AX12

ATC

aripiprazole; systemic

5.7

323.0

2358

3075

A02BC01

ATC

omeprazole; systemic

2.1

323.0

5954

22453

M03BX02

ATC

tizanidine; oral

1.9

323.0

17465

92527

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

9.3

323.0

980

744

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

323.0

4577

15737

N05CF02

ATC

zolpidem; oral

20.8

323.0

13561

8722

N06AX21

ATC

duloxetine; oral

4.0

323.0

4204

8116

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.4

323.0

2313

3863

N02AA05

ATC

oxycodone; systemic

2.8

323.0

2531

6544

J01AA02

ATC

doxycycline; systemic

1.8

323.0

19221

108900

N05BA06

ATC

lorazepam; systemic, sublingual

7.5

323.0

1766

1706

P15

ICPC

Chronic alcohol abuse

5.3

323.0

1448

1964

N06AB03

ATC

fluoxetine; oral

4.9

323.0

5153

8505

A02BC05

ATC

esomeprazole; systemic

2.0

323.0

9827

41792

N02AX02

ATC

tramadol; systemic, rectal

2.4

323.0

11362

42791

N06AB10

ATC

escitalopram; oral

3.7

323.0

8892

21979

P99

ICPC

Psychological disorders other

4.9

323.0

1274

1853

N06AX26

ATC

vortioxetine; oral

3.6

323.0

2397

4832

N06AG02

ATC

moclobemide; oral

5.7

323.0

1509

1911

N06AB06

ATC

sertraline; oral

4.5

323.0

5106

9161

N05BA01

ATC

diazepam; systemic, rectal

7.7

323.0

6200

6962

N05CD07

ATC

temazepam; oral

30.7

323.0

5595

1571

N03AX16

ATC

pregabalin; oral

3.2

323.0

7152

18634

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

8.3

323.0

980

832

P29

ICPC

Psychological sympt/compl other

3.1

323.0

2176

5088

N06AX16

ATC

venlafaxine; oral

5.1

323.0

7095

12191

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.4

323.0

2981

5076

N05BE01

ATC

buspirone; oral

9.1

323.0

1559

1235

N05CF01

ATC

zopiclone; oral

35.3

323.0

19852

14279

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.4

323.0

1247

1066

F31.8

ICD-10 Finland

Other bipolar affective disorders

6.5

323.0

1068

1171

F51.0

ICD-10 Finland

Nonorganic insomnia

5.1

323.0

6649

11214

N05AA02

ATC

levomepromazine; systemic

14.5

323.0

2778

1454

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.5

323.0

1941

4015

N06AX03

ATC

mianserin; oral

10.6

323.0

2029

1417

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

323.0

12833

57394

N03AE01

ATC

clonazepam; systemic

6.5

323.0

2394

2736

A02BC03

ATC

lansoprazole; oral

2.1

323.0

6393

24352

C07AA05

ATC

propranolol; systemic

3.4

323.0

7247

18091

N06AX11

ATC

mirtazapine; oral

8.7

323.0

15693

26198

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

6.1

323.0

2670

3264

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.3

323.0

1228

1062

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

7.9

323.0

2263

2131

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.1

323.0

5780

11634

C03CA01

ATC

furosemide; systemic

2.6

323.0

3290

9461

N05AH02

ATC

clozapine; systemic

5.5

323.0

1105

1427

N06AX05

ATC

trazodone; oral

11.7

323.0

1402

865

N05BA02

ATC

chlordiazepoxide; systemic

11.7

323.0

1227

751

N05BA12

ATC

alprazolam; oral

5.4

323.0

4278

6216

F34.1

ICD-10 Finland

Dysthymia

4.5

323.0

1413

2227

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.7

323.0

1923

2972

A06AD11

ATC

lactulose; oral

3.6

323.0

2648

5455

N03AX12

ATC

gabapentin; oral

2.9

323.0

4398

11550

N05AH04

ATC

quetiapine; oral

8.5

323.0

10616

13309

N02BE01

ATC

paracetamol; systemic, rectal

2.2

323.0

21593

121873

C07AB07

ATC

bisoprolol; oral

2.2

323.0

8769

33529

A02BC02

ATC

pantoprazole; systemic

2.2

323.0

16200

75257

T36

ICD-10 Finland

Poisoning by systemic antibiotics

7.6

323.0

2837

2836

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.9

323.0

1003

1037

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.9

323.0

3438

5330

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.6

323.0

3757

7938

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

7.9

323.0

1434

1303

N06AB08

ATC

fluvoxamine; oral

7.0

323.0

1081

1101

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

7.1

323.0

1602

1635

N06AA12

ATC

doxepin; systemic

11.1

323.0

2042

1361

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

323.0

10569

45462

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

8.3

323.0

887

754

P06

ICPC

Sleep disturbance

3.3

323.0

3416

7845

N06AA09

ATC

amitriptyline; systemic

4.7

323.0

2742

4358

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.7

323.0

2882

4567

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.5

323.0

3562

5030

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

323.0

3520

8774

SPAT1240

SPAT

Therapeutic discussion

2.4

323.0

3667

11584

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

5.2

323.0

2166

3061

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.5

323.0

3961

8768

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

7.4

323.0

1156

1113

F61.0

ICD-10 Finland

Mixed personality disorders

7.5

323.0

1062

1012

P01

ICPC

Feeling anxious/nervous/tense

2.3

323.0

3433

10842

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.3

323.0

4366

14259

N05AN01

ATC

lithium; oral

8.0

323.0

1439

1293

N03AG01

ATC

valproic acid; systemic, rectal

6.1

323.0

3210

4000

N05AX08

ATC

risperidone; systemic

5.9

323.0

3092

3967

N07BB01

ATC

disulfiram; oral

6.4

323.0

2892

3412

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

323.0

3780

9163

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.7

322.7

1058

1320

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

322.5

1728

3529

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

321.9

8930

40986

N05AB01

ATC

dixyrazine; systemic

15.5

318.5

593

268

V03AA01

ATC

8.4

317.9

793

665

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.6

316.3

1045

1316

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

312.0

9175

42758

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.4

311.0

843

808

A02BA02

ATC

ranitidine; systemic

2.2

307.9

3761

12671

J01DB01

ATC

cefalexin; oral

1.8

307.6

21215

125746

R03AC02

ATC

salbutamol; inhalant

1.6

305.3

13087

67739

M01AB05

ATC

diclofenac; systemic, rectal

1.7

304.6

17225

96102

M79.6

ICD-10 Finland

Pain in limb

1.7

303.8

8065

36354

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

7.9

303.8

786

700

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

302.6

3260

10337

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.3

301.6

910

1018

M54.5

ICD-10 Finland

Low back pain

1.7

299.9

8428

38620

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

299.2

8467

38876

H02AB06

ATC

prednisolone; systemic

1.7

296.7

10435

51000

F10.24

ICD-10 Finland

Alcohol depence active use

7.3

296.3

805

774

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

296.0

6914

29866

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

5.3

295.8

1025

1366

J01MA02

ATC

ciprofloxacin; systemic

1.7

292.7

8313

38146

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.4

288.8

1193

1924

P03

ICPC

Feeling depressed

2.4

282.8

2954

9202

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.4

281.5

757

716

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

279.0

5176

20590

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

276.9

2950

9275

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

275.1

4416

16625

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

271.8

3964

14355

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

271.5

7402

33378

M01AH05

ATC

etoricoxib; oral

1.6

269.8

14970

81694

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

268.9

5741

23937

R06.0

ICD-10 Finland

Dyspnoea

1.9

268.9

4633

17905

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.4

268.5

1122

1828

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.5

268.0

2393

6848

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

263.4

2052

5422

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

8.2

257.9

652

558

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.3

257.0

895

1198

WX110

NOMESCO Finland

Local anesthesy

1.6

256.2

18071

104047

M01AE02

ATC

naproxen; oral, rectal

1.6

254.6

14257

77444

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.1

254.3

606

468

N05AD03

ATC

melperone; systemic

17.0

250.8

451

185

P01AB01

ATC

metronidazole; oral, rectal

1.6

248.5

9218

45051

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

247.2

1938

5133

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.3

245.6

1041

1718

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.8

243.8

918

1341

C10AA01

ATC

simvastatin; oral

1.8

242.6

5496

23246

R53

ICD-10 Finland

Malaise and fatigue

1.9

242.5

4464

17594

N04BC05

ATC

pramipexole; oral

3.4

241.8

1372

2913

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.1

239.4

665

660

P72

ICPC

Schizophrenia

5.1

235.7

836

1142

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.8

235.1

883

1286

F32

ICD-10 Finland

Depressive episode

2.8

235.1

1775

4590

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

234.6

4449

17696

S18

ICPC

Laceration/cut

1.6

234.2

8217

39408

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.4

233.8

968

1560

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.0

232.6

1067

1896

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

232.5

9764

49013

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

232.5

14457

79694

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.5

232.4

935

1464

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.6

232.0

615

568

P74

ICPC

Anxiety disorder/anxiety state

3.3

231.8

1357

2949

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.6

229.4

1179

2312

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

227.5

3543

13083

R51.80

ICD-10 Finland

Headache

1.9

227.5

3972

15318

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.4

227.2

932

1488

N03AF01

ATC

carbamazepine; oral, rectal

3.4

226.4

1238

2552

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

224.8

6095

27143

R4110

NOMESCO Finland

Physiotherapy

1.7

224.5

5592

24276

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

7.5

223.7

599

562

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

7.2

223.4

613

597

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

26.7

220.7

346

N05AL01

ATC

sulpiride; systemic

8.9

220.4

530

416

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

220.0

753

986

J01FF01

ATC

clindamycin; systemic

1.7

219.1

6364

28871

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

4.0

218.4

1000

1773

P18

ICPC

Medication abuse

16.1

218.3

400

173

G04CA02

ATC

tamsulosin; oral

2.0

218.2

3542

13273

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

10.5

217.6

478

316

F31

ICD-10 Finland

Bipolar affective disorder

6.8

214.5

613

634

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

213.9

18792

111061

P16

ICPC

Acute alcohol abuse

5.3

213.7

744

994

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

213.5

12718

68825

N05AF01

ATC

flupentixol; systemic

8.3

212.0

531

447

L03

ICPC

Low back symptom/complaint

1.7

210.8

5276

22872

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

210.0

4141

16621

J01MA12

ATC

levofloxacin; systemic

1.9

210.0

3549

13485

N05AC02

ATC

thioridazine; oral

5.6

209.9

696

877

N03AX11

ATC

topiramate; oral

3.8

209.1

1001

1846

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.8

208.9

665

796

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.1

208.1

573

561

L17

ICPC

Foot/toe symptom/complaint

1.8

207.6

4723

19864

C08CA01

ATC

amlodipine; oral

1.7

207.1

5208

22591

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.0

206.9

1377

3273

A10BA02

ATC

metformin; oral

1.8

206.5

4667

19585

H03AA01

ATC

levothyroxine sodium; systemic

1.8

205.5

4279

17481

G47.3

ICD-10 Finland

Sleep apnoea

1.7

205.3

5308

23207

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

204.0

4626

19424

C07AB02

ATC

metoprolol; systemic

2.1

204.0

2650

9053

T90

ICPC

Diabetes non-insulin dependent

1.9

203.7

3799

14941

A28

ICPC

Limited function/disability NOS

2.7

202.6

1562

4079

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.5

202.4

1084

2195

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

202.3

3338

12555

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

9.1

201.9

479

367

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

200.4

7477

36087

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

200.1

5077

22047

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.7

196.5

1587

4258

R06AE07

ATC

cetirizine; oral

1.5

195.7

10633

55972

N05AF05

ATC

zuclopenthixol; systemic

8.2

193.7

488

415

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

25.7

192.2

304

SPAT1254

SPAT

Administration of medicine

2.1

191.6

2574

8904

Z71.8

ICD-10 Finland

Other specified counselling

1.6

191.5

5810

26502

A01

ICPC

Pain general/multiple sites

2.6

191.2

1564

4227

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

20.4

191.1

323

110

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

12.3

190.9

390

221

UJF32

NOMESCO Finland

Coloscopy

1.8

190.6

4384

18440

S06.0

ICD-10 Finland

Concussion

2.1

188.8

2480

8495

J02AC01

ATC

fluconazole; systemic

1.5

188.7

9349

48087

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

188.3

7435

36266

L28

ICPC

Limited function/disability (L)

2.3

188.2

2088

6626

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

12.7

186.8

376

206

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.5

186.0

750

1175

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

185.7

3558

14085

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.0

184.0

672

947

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

183.8

2270

7563

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.7

182.7

445

357

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.1

182.6

815

1409

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.7

182.6

1433

3776

EBA00

NOMESCO Finland

Extraction of tooth

1.5

181.5

7845

39019

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

179.9

4165

17518

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

179.5

3287

12794

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

7.1

176.5

485

473

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

176.0

1758

5291

R03BB04

ATC

tiotropium bromide; inhalant

2.6

176.0

1433

3858

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

174.8

2831

10527

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.4

174.5

969

2015

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

174.1

3838

15882

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

173.4

12759

70890

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

171.4

9878

52170

N05AE04

ATC

ziprasidone; systemic

8.8

171.1

412

324

WX002

NOMESCO Finland

Sedation and analgesia

1.8

171.0

3532

14302

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.3

170.9

721

1181

F40.1

ICD-10 Finland

Social phobias

3.5

170.5

902

1806

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.0

169.6

1139

2716

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

168.9

3624

14851

N07BA03

ATC

varenicline; oral

2.3

167.7

1730

5288

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

167.6

3505

14242

J01DA01

ATC

[U] cefalexin; systemic

1.4

166.8

15075

86910

R02

ICPC

Shortness of breath/dyspnoea

2.1

166.1

2164

7365

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

7.6

165.9

436

397

P19

ICPC

Drug abuse

6.6

165.4

480

507

UKC02

NOMESCO Finland

Cystoscopy

2.0

165.2

2370

8396

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

164.9

1670

5056

E0000UV

ATC

1.5

163.9

8696

45009

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

163.2

4537

20071

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.3

163.2

930

1971

J01FA06

ATC

roxithromycin; oral

1.5

163.1

8986

46868

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

162.0

10389

55871

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

161.7

5697

26824

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

161.7

6175

29656

N06AA04

ATC

clomipramine; systemic

5.6

160.8

531

665

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

160.8

4861

21996

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.3

160.2

433

412

M01AC06

ATC

meloxicam; systemic, rectal

1.5

159.5

7329

36713

SPAT1301

SPAT

No procedures

1.6

159.1

5992

28662

N06BA04

ATC

methylphenidate; oral

3.3

158.9

904

1915

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

158.5

2154

7457

M02AA07

ATC

piroxicam; topical

1.5

157.6

6636

32575

M01AX17

ATC

nimesulide; oral

1.7

156.4

4112

17881

R11

ICD-10 Finland

Nausea and vomiting

2.3

156.2

1634

5022

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

155.5

4504

20118

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.9

155.4

398

348

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.4

154.8

461

505

WX290

NOMESCO Finland

Other blockade of nerve

1.4

154.8

12627

70912

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

7.2

153.3

420

408

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

152.2

23807

152484

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

151.6

6497

31961

C10AA05

ATC

atorvastatin; oral

1.6

151.2

5400

25442

R42

ICD-10 Finland

Dizziness and giddiness

1.7

151.1

3439

14313

N06AX18

ATC

reboxetine; oral

7.3

150.7

407

387

Z72.2

ICD-10 Finland

Drug use

9.5

150.0

347

254

SPAT1234

SPAT

Support of social functional capacity

3.4

149.2

823

1701

SPAT1265

SPAT

Breathalyser

5.5

148.8

498

634

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.8

147.6

553

801

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

11.2

147.5

313

193

F41.00

ICD-10 Finland

Moderate panic disorder

4.0

147.4

660

1143

G44.2

ICD-10 Finland

Tension-type headache

1.8

147.3

3102

12588

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

147.3

2136

7584

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

147.1

2561

9742

AA400

NOMESCO Finland

Electroconvulsive therapy

7.4

146.4

393

370

K02.1

ICD-10 Finland

Caries of dentine

1.4

146.0

15162

88581

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

14.5

145.9

277

132

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.3

145.7

501

659

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.4

145.6

361

299

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

16.2

145.5

265

113

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.1

145.2

635

1076

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

145.0

4391

19806

M25.5

ICD-10 Finland

Pain in joint

1.5

144.3

6358

31409

F33

ICD-10 Finland

Recurrent depressive disorder

3.7

143.3

718

1373

N06AX17

ATC

milnacipran; oral

6.5

143.3

420

450

J01FA10

ATC

azithromycin; systemic

1.4

143.1

14661

85287

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

143.0

1509

4653

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

142.7

1924

6624

K59.09

ICD-10 Finland

Constipation, unspecified

3.0

141.9

939

2214

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

141.5

2252

8283

B01AB05

ATC

enoxaparin; parenteral

1.6

141.3

5127

24191

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

140.9

1685

5509

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.6

139.9

1192

3284

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

139.2

13268

76021

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

139.0

2017

7155

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.1

138.7

845

1881

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

138.5

1493

18539

SPAT1260

SPAT

Consultation of another employee

1.7

138.2

3338

14112

A46

ICD-10 Finland

Erysipelas

1.9

138.1

2408

9153

XKD00

NOMESCO Finland

Uroflowmetry

1.9

137.8

2364

8933

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

9.1

137.7

326

249

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

137.2

3700

36775

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

17.9

137.1

241

Z72.1

ICD-10 Finland

Alcohol use

5.0

136.5

493

686

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

5.7

136.4

441

538

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

136.4

3511

15115

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.1

135.8

603

1036

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

135.6

1671

5531

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

135.2

4281

19493

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

134.6

987

2487

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

134.5

4493

42837

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.7

134.4

509

746

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

6.9

134.4

378

382

N05CD05

ATC

triazolam; oral, sublingual

32.1

133.7

200

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.3

133.7

1412

4351

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

133.4

3713

16331

ZXA00

NOMESCO Finland

Right side

1.6

133.0

4430

20423

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

8.1

132.5

336

289

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

132.2

3264

13872

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

9.4

131.7

305

224

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.5

131.6

386

414

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

131.5

4675

21892

W78

ICPC

Pregnancy

0.6

131.4

1726

20323

R52.2

ICD-10 Finland

Other chronic pain

3.1

131.4

805

1799

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

11.1

131.2

280

175

E66.8

ICD-10 Finland

Other obesity

2.2

130.9

1509

4846

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

9.7

130.5

297

211

R01AD09

ATC

mometasone; nasal

1.4

130.4

11076

61902

R50.9

ICD-10 Finland

Fever, unspecified

1.7

129.3

2950

12239

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.8

129.3

613

1118

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

129.0

847

1985

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

15.6

128.4

237

105

D11

ICPC

Diarrhoea

1.8

128.2

2822

11578

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

127.8

6830

34968

A04

ICPC

Weakness/tiredness general

1.9

127.3

2310

8892

H02AB07

ATC

prednisone; oral

1.8

126.8

2610

10476

N06AA10

ATC

nortriptyline; systemic

3.8

126.6

599

1090

R33

ICD-10 Finland

Retention of urine

2.6

126.2

1016

2708

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

125.9

1861

6639

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.6

125.7

409

503

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

125.5

1805

6370

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.9

125.1

855

2058

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

19.4

124.4

213

WX892

NOMESCO Finland

Monitored bed care

2.2

123.8

1434

4612

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.4

123.6

305

251

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

122.7

1747

6138

L08

ICPC

Shoulder symptom/complaint

1.6

122.3

3418

15016

SPAT1252

SPAT

Overall medication plan or its review

2.6

121.9

1006

2719

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

121.9

916

2342

S29

ICPC

Skin symptom/complaint other

1.7

121.4

2863

11980

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

121.3

3814

17283

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

8.1

121.1

306

262

N03AF02

ATC

oxcarbazepine; oral

2.9

121.0

839

2038

T74.1

ICD-10 Finland

Physical abuse

3.2

121.0

718

1567

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.7

120.8

591

1107

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.9

120.7

846

2070

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

7.2

120.4

327

314

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.7

120.3

914

2352

-1

NOMESCO Finland

1.4

120.2

8403

45161

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

9.9

120.0

271

190

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

119.7

2392

9498

ZXA05

NOMESCO Finland

Left side

1.6

119.7

4057

18727

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

119.3

2267

8854

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

119.0

1838

6664

Z00.0

ICD-10 Finland

General medical examination

1.6

118.5

3546

15853

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

118.2

1078

3079

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

117.5

1175

3519

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

116.9

1781

6421

D07AC01

ATC

betamethasone; topical

1.4

116.7

6944

36176

SPAT1310

SPAT

Counselling related to known health issue

1.5

116.6

6192

31546

SPAT1380

SPAT

Postpartum check-up

0.5

116.6

883

12243

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.3

116.5

1229

3780

F61

ICD-10 Finland

Mixed and other personality disorders

8.9

116.4

278

216

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

116.3

4526

21574

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

116.3

14941

88724

SPAT1216

SPAT

Assessment of functional ability

1.9

116.2

1827

6666

R05FB02

ATC

cough suppressants and expectorants

1.4

116.1

6895

35896

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

114.9

2486

10123

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.1

114.6

214

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

114.2

1269

3999

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

114.2

2353

9430

K08.3

ICD-10 Finland

Retained dental root

2.1

114.0

1452

4865

L01

ICPC

Neck symptom/complaint

1.7

113.4

2732

11487

C09CA06

ATC

candesartan; oral

1.6

113.4

3997

18601

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

13.9

113.2

218

108

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

113.1

1717

6180

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.9

112.7

353

414

M01AH02

ATC

rofecoxib; oral

1.9

112.4

1854

6883

R05

ICPC

Cough

1.5

112.4

4318

20502

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

111.8

4228

19998

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

111.4

2352

9497

S01.0

ICD-10 Finland

Open wound of scalp

2.1

110.0

1465

5003

SPAT1379

SPAT

Health check-up of pregnant person

0.5

110.0

1162

14576

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.7

109.5

355

435

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.2

109.4

1287

4164

K05.31

ICD-10 Finland

Periodontitis pronounced

1.9

109.3

1779

6570

A02BA04

ATC

nizatidine; systemic

2.3

108.4

1154

3562

R35

ICD-10 Finland

Polyuria

2.4

108.4

1058

3129

R55

ICD-10 Finland

Syncope and collapse

2.0

108.3

1596

5674

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

11.9

107.7

222

129

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

107.7

1032

3022

G04BD12

ATC

mirabegron; oral

2.3

107.7

1107

3359

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

107.2

2539

10613

JN4BD

NOMESCO Finland

Extensive body CT

2.0

106.8

1622

5833

F60.8

ICD-10 Finland

Other specific personality disorders

6.0

106.4

328

377

M48.0

ICD-10 Finland

Spinal stenosis

2.1

106.1

1329

4418

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

106.0

4372

21059

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

106.0

873

2356

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

105.4

1937

7466

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

103.5

1742

6508

KMAK

NOMESCO Finland

1.3

103.4

13762

81437

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

103.3

5101

25506

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

103.2

2255

23626

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

103.1

494

909

M79.1

ICD-10 Finland

Myalgia

1.6

103.1

2783

12065

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

103.1

797

2072

F22.0

ICD-10 Finland

Delusional disorder

4.5

102.7

407

626

A29

ICPC

General symptom/complaint other

1.9

102.1

1801

6840

R41.0

ICD-10 Finland

Disorientation, unspecified

4.6

101.8

395

595

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

101.6

1177

3779

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.9

101.1

471

846

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

100.6

6151

32028

205

Kela drug reimbursment

Chronic hypertension

1.6

100.3

2871

12640

R03DC03

ATC

montelukast; oral

1.6

100.3

3476

16063

R03BA01

ATC

beclometasone; inhalant

1.7

99.7

2677

11583

L02

ICPC

Back symptom/complaint

1.8

99.6

1908

7451

S10

ICPC

Boil/carbuncle

2.2

99.6

1149

3682

SPAT1262

SPAT

Handing over of treatment supplies

1.6

98.9

3063

13760

J01EA01

ATC

trimethoprim; systemic

1.5

98.6

3997

19140

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

7.2

98.2

266

255

G04CA01

ATC

alfuzosin; oral

1.8

98.1

1988

7907

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

98.0

9373

52580

C10AA07

ATC

rosuvastatin; oral

1.5

97.7

3451

16010

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

97.6

805

2173

R4120

NOMESCO Finland

Occupational therapy

2.1

97.5

1305

4459

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

97.5

1706

6459

J05AB01

ATC

aciclovir; systemic

1.5

97.4

4181

20272

X58

ICD-10 Finland

Exposure to other specified factors

1.6

97.3

3347

15427

J01CA04

ATC

amoxicillin; systemic

1.4

97.1

20075

126399

R06AX27

ATC

desloratadine; oral

1.4

97.1

6718

35721

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.4

97.0

538

1116

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.0

96.9

615

1407

K85

ICPC

Elevated blood pressure

1.8

96.3

1768

6803

V03AB30

ATC

8.3

95.7

238

199

L15

ICPC

Knee symptom/complaint

1.6

95.5

3262

15006

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

12.9

95.2

189

101

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

95.1

1596

5948

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

95.0

2084

21853

E000001

ATC

1.5

94.8

4320

21198

K92.0

ICD-10 Finland

Haematemesis

3.5

94.7

500

998

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

94.7

5100

25876

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

94.6

2398

10200

R52.9

ICD-10 Finland

Pain, unspecified

1.9

94.5

1589

5929

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

94.3

1071

13198

F20

ICD-10 Finland

Schizophrenia

6.0

94.0

290

334

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

93.8

867

2491

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

93.6

2485

10705

WZA90

NOMESCO Finland

Other doctors statement

1.4

93.6

4923

24856

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

93.5

1684

18458

G04BD08

ATC

solifenacin; oral

2.6

93.4

741

1955

F32.8

ICD-10 Finland

Other depressive episodes

3.5

93.4

488

966

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

8.3

93.3

232

194

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

93.2

1289

4463

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

92.8

2153

8921

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

92.4

1266

4367

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

92.0

1880

7489

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

91.7

1370

4889

R01AD08

ATC

fluticasone; nasal

1.4

91.7

6614

35345

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.6

91.5

297

365

C09AA05

ATC

ramipril; oral

1.6

91.3

3095

14198

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

91.0

1107

3630

D01

ICPC

Abdominal pain/cramps general

1.7

90.8

2122

8811

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

90.8

8166

45221

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

90.7

1178

3973

SPAT1227

SPAT

Substance abuse rehabilitation

5.1

90.7

318

429

R07.3

ICD-10 Finland

Other chest pain

1.9

90.5

1587

6005

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

90.3

2482

10787

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.9

90.2

411

724

T82

ICPC

Obesity

2.3

90.0

943

2885

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

21.4

90.0

149

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

6.9

90.0

252

254

R60.0

ICD-10 Finland

Localized oedema

1.9

89.8

1497

5565

K59.0

ICD-10 Finland

Constipation

2.5

89.5

763

2096

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

89.3

1668

18146

J01MA14

ATC

moxifloxacin; systemic

1.8

89.1

1656

6393

R03BA02

ATC

budesonide; inhalant

1.5

88.9

3507

16655

WX402

NOMESCO Finland

General anaesthesia

1.5

88.6

3650

17499

SPAT1097

SPAT

Recording of ECG

1.7

88.6

2036

8409

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

88.5

1068

3489

N05AC01

ATC

periciazine; systemic

12.6

88.3

177

H02AB04

ATC

methylprednisolone; systemic

1.6

88.2

2629

11671

N03AX14

ATC

levetiracetam; systemic

2.9

88.2

600

1439

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

88.1

2329

10012

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

87.9

3540

16882

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.6

87.9

441

845

C05AA08

ATC

fluocortolone; rectal, topical

1.6

87.8

2704

12102

J20

ICD-10 Finland

Acute bronchitis

1.8

87.7

1795

7152

M54

ICD-10 Finland

Dorsalgia

1.6

87.6

2555

11277

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

87.5

862

2557

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.4

87.5

808

2319

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

7.1

87.4

240

235

G72.8

ICD-10 Finland

Other specified myopathies

5.3

87.4

300

395

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.2

87.2

506

1086

A07AA02

ATC

nystatin; oral

2.3

87.0

862

2567

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.2

86.5

520

1146

M02AA10

ATC

ketoprofen; topical

1.6

86.3

2697

12113

SPAT1229

SPAT

Assessment of need for aid

2.3

86.1

894

2722

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.4

85.7

464

945

183

Kela drug reimbursment

Lamotrigin and topiramate

4.5

85.5

340

526

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

85.4

5064

26087

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

85.2

1972

8158

W19

ICD-10 Finland

Unspecified fall

1.8

84.7

1677

6610

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

84.3

534

1221

M01AB01

ATC

indometacin; systemic, rectal

2.1

84.1

1070

3575

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

84.0

1916

7892

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.7

83.9

650

1691

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

83.9

1103

3736

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.9

83.8

308

438

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

83.8

5587

29372

RS220

NOMESCO Finland

3.9

83.7

390

701

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

9.0

83.7

198

152

SPAT1263

SPAT

Sampling

1.3

83.7

8660

48823

F05.9

ICD-10 Finland

Delirium, unspecified

5.0

83.2

297

409

E87.6

ICD-10 Finland

Hypokalaemia

3.2

83.2

486

1049

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

83.1

1551

5992

R96

ICPC

Asthma

1.9

82.9

1400

5226

SPAT1196

SPAT

Monitoring of normal pregnancy

0.5

82.6

715

9547

C03DA01

ATC

spironolactone; oral

1.9

82.5

1308

4768

S22.3

ICD-10 Finland

Fracture of rib

2.0

82.3

1224

4356

L12

ICPC

Hand/finger symptom/complaint

1.6

82.3

2633

11887

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

82.2

1015

3347

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

82.2

16322

100531

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

82.1

1056

3545

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

5.8

81.9

258

306

N05BA05

ATC

potassium clorazepate; oral

8.8

81.8

196

154

A11

ICPC

Chest pain NOS

2.1

81.7

1093

3729

R03AC03

ATC

terbutaline; inhalant

1.6

81.5

2804

12880

SPAT1153

SPAT

Removal of sutures

1.4

81.4

5230

27299

C09AA02

ATC

enalapril; systemic

1.6

81.2

2333

10244

ZX120

NOMESCO Finland

Intravenous

1.8

81.0

1606

6328

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

81.0

799

2373

M79.7

ICD-10 Finland

Fibromyalgia

2.5

81.0

722

2035

R05

ICD-10 Finland

Cough

1.5

80.5

3272

15610

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

80.5

525

1224

Z08

ICPC

Social welfare problem

4.0

80.2

357

616

F60.2

ICD-10 Finland

Dissocial personality disorder

8.5

80.1

196

160

M04AA01

ATC

allopurinol; systemic

1.8

79.8

1518

5899

R03BA05

ATC

fluticasone; inhalant

1.5

79.7

3649

17851

M03BX01

ATC

baclofen; systemic

3.4

79.6

427

864

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.7

79.5

2217

22207

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

79.5

17700

110431

A01AB09

ATC

miconazole; local oral

1.9

79.3

1276

4679

G04BD04

ATC

oxybutynin; oral, transdermal

2.9

79.1

543

1309

C09CA01

ATC

losartan; oral

1.5

78.9

3339

16062

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

4.7

78.9

298

437

D12

ICPC

Constipation

3.2

78.6

467

1021

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

10.6

78.3

170

111

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3009508) Creatinine [Moles/volume] in Urine

20201

90160

1.42

321.39

3.5

3.2

7.4

8.0

mmol/l

3.31

16952

76227

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

12332

49966

1.52

319.95

3.1

3.0

2.5

2.4

mmol/l

3.06

10704

43634

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5815

19448

1.80

317.82

1.7

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13199

54335

1.50

317.52

4.1

3.5

316.0

568.2

ng/l

7.95

9882

40522

(3022948) Iron [Moles/volume] in Serum or Plasma

11325

45111

1.54

317.10

2.6

2.5

12.9

13.9

umol/l

1.38

10398

41969

(3033658) Prothrombin time (PT) actual/Normal

17388

74590

1.47

307.65

4.6

3.8

91.1

90.8

0.97

16883

72731

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1142

1164

5.75

307.65

12.9

11.6

0.6

mmol/l

0.09

1042

1076

(36304419) Bacteria [Presence] in Urine

18199

77666

1.49

307.65

3.5

3.0

—

(3018010) Neutrophils/100 leukocytes in Blood

31319

142682

1.51

307.65

6.8

5.8

57.5

57.2

4.01

29283

134012

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

35164

150954

1.74

307.65

7.0

5.9

10.8

11.5

umol/l

14.25

33190

143159

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

33486

140827

1.76

307.65

7.6

6.5

1.2

mmol/l

1.42

28362

118788

(3013650) Neutrophils [#/volume] in Blood by Automated count

37264

172146

1.57

307.65

11.3

8.6

4.2

4.1

e9/l

10.36

32856

150486

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8462

31085

1.66

307.65

7.4

7.5

5.1

kpa

4.69

8047

29678

(3018095) Leukocytes [#/volume] in Urine

23122

102696

1.46

307.65

4.3

3.5

90.3

93.8

e6/l

0.20

16909

71905

(3019198) Lymphocytes [#/volume] in Blood

33683

153581

1.54

307.65

6.8

5.8

1.9

e9/l

0.05

29791

135886

(3024561) Albumin [Mass/volume] in Serum or Plasma

29522

123519

1.69

307.65

5.3

4.7

35.4

35.7

g/l

13.91

27390

114764

(3044889) 12 lead EKG panel

42207

208655

1.47

307.65

4.2

3.5

—

(3032080) INR in Blood by Coagulation assay

26542

115175

1.55

307.65

9.6

8.3

1.2

inr

1.02

7831

33474

(3030467) Casts [#/volume] in Urine by Automated count

18594

79605

1.49

307.65

3.5

3.0

0.4

e6/l

0.20

14275

59364

(3037467) Urinalysis macro (dipstick) panel - Urine

42131

206323

1.50

307.65

4.9

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

24474

108638

1.48

307.65

4.0

3.3

57.4

65.1

ng/l

0.28

16595

70065

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12230

45152

1.69

307.65

3.7

3.4

0.8

mmol/l

12.09

11360

42245

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

22696

90970

1.67

307.65

2.9

2.5

56.5

58.6

u/l

3.57

20860

84203

(3026008) Bacteria identified in Urine by Culture

19337

81986

1.51

307.65

3.4

2.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

45385

223433

1.55

307.65

4.5

3.9

12.5

11.5

mm/h

35.33

42088

207943

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1090

1430

4.46

307.65

19.4

17.8

2370.7

2985.0

nmol/l

0.17

1050

1360

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

48527

229257

1.83

307.65

8.9

7.1

78.8

77.5

u/l

6.58

45912

216175

(40758558) Short blood count panel - Blood

17482

73915

1.50

307.65

8.3

6.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18150

76730

1.51

307.65

3.1

2.9

1417.4

1350.8

ng/l

0.98

15281

65249

(3001122) Ferritin [Mass/volume] in Serum or Plasma

28533

130963

1.46

307.65

3.1

2.8

131.1

124.5

ug/l

2.49

26349

122310

(3009466) Valproate [Moles/volume] in Serum or Plasma

2288

3217

4.22

307.65

6.0

4.5

379.2

361.9

umol/l

4.82

2026

2756

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

17596

70373

1.61

307.65

2.4

2.2

2.9

mg/l

0.73

15003

60375

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

46993

232716

1.57

307.65

4.6

3.8

14.6

14.7

pmol/l

8.40

43130

213449

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

53752

280250

1.58

307.65

5.6

4.5

2.0

2.1

mu/l

0.74

49762

258615

(42870588) Differential panel, method unspecified - Blood

23703

99843

1.58

307.65

6.5

5.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

27205

119848

1.53

307.65

2.4

2.2

77.5

830.9

nmol/l

0.50

24688

108663

(3006504) Eosinophils/100 leukocytes in Blood

31048

139639

1.54

307.65

6.9

5.9

2.8

2.9

6.02

28971

130568

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23972

97592

1.66

307.65

3.8

3.1

35.0

33.2

u/l

1.36

22659

92706

(3027801) Oxygen [Partial pressure] in Arterial blood

8454

31070

1.66

307.65

7.4

7.5

12.0

12.6

kpa

24.84

8042

29652

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

20924

86028

1.59

307.65

2.4

2.0

235.0

204.0

u/l

2.18

19612

80876

(3019069) Monocytes/100 leukocytes in Blood

31195

140430

1.54

307.65

7.2

6.2

8.6

8.5

0.72

29256

131982

(3013826) Glucose [Moles/volume] in Serum or Plasma

37429

172187

1.59

307.65

5.6

4.5

6.7

mmol/l

0.84

35276

160258

(3006315) Basophils [#/volume] in Blood

33118

149464

1.56

307.65

6.8

5.8

0.0

e9/l

0.57

28881

129797

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1033

1360

4.44

307.65

14.3

12.5

855.7

1550.8

nmol/l

0.47

1000

1310

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7350

25802

1.73

307.65

2.3

2.2

364.6

373.8

nmol/l

3.23

6755

23869

(3028707) Methadone [Presence] in Urine by Screen method

2433

4028

3.59

307.65

4.1

2.4

—

(3026782) Osmolality of Urine

13829

55323

1.56

307.65

3.1

2.7

523.2

555.7

mosm/kgh2o

44.08

11878

47109

(3001604) Monocytes [#/volume] in Blood

32987

148755

1.56

307.65

6.8

5.7

0.6

e9/l

19.67

28756

129226

(3011288) Drugs identified in Urine by Screen method

2911

7002

2.47

307.65

5.1

2.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9893

36121

1.69

307.65

6.3

6.0

1.0

mmol/l

0.38

9245

33767

(3015377) Calcium [Moles/volume] in Serum or Plasma

23107

94567

1.63

307.65

3.6

3.3

2.4

mmol/l

0.11

20250

83012

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11106

36479

1.91

307.65

2.2

1.7

1.6

1.4

56.40

9656

32477

(3023103) Potassium [Moles/volume] in Serum or Plasma

58569

315235

1.64

307.65

21.2

14.4

4.0

mmol/l

3.14

57285

306708

(3002582) Erythrocytes [#/volume] in Urine

20226

87218

1.49

307.65

3.7

3.1

73.2

94.6

e6/l

1.28

15829

66465

(3003396) Base excess in Arterial blood by calculation

8462

31092

1.66

307.65

7.4

7.5

1.1

1.0

mmol/l

2.84

6719

24399

(3023368) Bacteria identified in Blood by Culture

19152

75229

1.66

307.65

4.9

4.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8312

29658

1.71

307.65

1.9

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

13614

49370

1.75

307.65

1.8

1.7

1175.1

1157.4

nmol/l

1.26

10333

37727

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

14382

59477

1.51

307.65

1.7

1.6

40948726.7

34855323.1

pmol/l

0.49

11832

49861

(3002030) Lymphocytes/100 leukocytes in Blood

31796

144778

1.52

307.65

7.0

6.0

27.6

28.2

13.33

29650

135381

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

27376

115019

1.64

307.65

2.1

1.9

96.5

95.9

pmol/l

1.08

14353

61406

(3031040) Bacteria [#/volume] in Urine by Automated count

40908

194044

1.57

307.65

5.2

4.0

1623.8

1235.4

e6/l

0.66

632

2627

(3013115) Eosinophils [#/volume] in Blood

34046

154405

1.56

307.65

7.3

5.9

0.2

e9/l

0.05

30057

136186

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

11648

44043

1.64

307.65

2.0

1.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

16241

62559

1.66

307.65

1.6

1.5

20.7

20.1

nmol/l

6.18

14103

53983

(3022096) Basophils/100 leukocytes in Blood

30212

135374

1.53

307.65

7.0

6.0

0.7

2.98

28209

126633

(3000850) Epithelial cells [#/volume] in Urine

14600

59918

1.52

307.65

2.9

2.5

5.7

5.4

e6/l

1.88

12798

52316

(3019550) Sodium [Moles/volume] in Serum or Plasma

58467

314213

1.64

307.65

21.1

14.3

139.4

139.7

mmol/l

140.38

57261

306303

(3018418) pH of Serum or Plasma

20737

82395

1.66

307.65

4.6

4.0

7.4

0.75

3948

15828

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

30844

126980

1.76

307.65

6.8

5.9

1.2

mmol/l

1.21

28134

115219

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8335

29795

1.71

307.65

1.9

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10500

41458

1.55

304.28

2.6

2.5

2.3

g/l

0.37

9599

38454

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

41373

209309

1.38

303.92

4.0

2.9

56.2

46.2

u/l

60.46

38602

196908

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7265

26247

1.67

302.10

2.8

2.5

38.1

46.6

u/l

1.29

6212

22550

(40768797) Stomach Pathology biopsy report

10043

39318

1.56

301.84

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8649

32903

1.60

292.74

2.9

2.7

8.5

umol/l

0.02

7262

28715

(1001926) Buprenorphine [Presence] in Urine by Screen method

3054

8371

2.16

292.25

3.8

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

9793

38420

1.56

290.46

2.7

2.6

22.2

23.2

8.74

8278

32996

(3042936) Bacteria identified in Isolate by Culture

10247

40769

1.54

284.90

2.2

2.0

—

(4198724)

794

969

4.78

281.61

2.4

2.3

—

(3016502) Oxygen saturation in Arterial blood

7519

27880

1.63

281.42

7.8

7.9

95.4

95.8

5.46

7256

26815

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7051

25976

1.64

269.92

2.4

2.3

0.2

g/l

1.18

6506

24216

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

52602

279197

1.43

269.63

6.4

5.4

39.7

39.5

mmol/mol

4.35

48806

260110

(3014111) Lactate [Moles/volume] in Serum or Plasma

6628

24172

1.65

263.49

7.1

7.3

1.4

1.3

mmol/l

1.38

6321

23356

(3027945) Reticulocytes/100 erythrocytes in Blood

7919

30263

1.58

260.41

2.6

2.5

1.8

1.7

8.47

6940

26925

(3021589) Normoblasts [#/volume] in Blood

27664

133271

1.34

259.95

11.3

9.1

0.0

e9/l

0.15

22740

109529

(3020779) Urea [Moles/volume] in Serum or Plasma

6677

24540

1.64

257.15

7.8

7.7

9.6

9.7

mmol/l

0.31

6358

23368

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

57205

309567

1.50

250.22

18.8

12.7

23.3

23.4

mg/l

0.05

47742

242335

(3015736) pH of Urine

23989

113731

1.34

246.39

3.8

3.2

5.7

5.8

0.10

(3007853) Bacteria identified in Skin by Aerobe culture

8711

34434

1.53

245.77

1.9

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6852

25850

1.59

236.12

8.3

121.2

122.2

g/l

3.32

6616

24918

(3023183) Ammonium ion [Moles/volume] in Plasma

2122

5463

2.29

234.61

2.9

2.7

34.5

33.9

umol/l

0.33

1822

4627

(3016879) Cocaine [Presence] in Urine

3354

10372

1.92

230.99

3.8

1.8

—

(3000991) Gas panel - Venous blood

6238

23200

1.61

227.39

8.6

8.7

—

(3002032) Base excess in Venous blood by calculation

6703

25376

1.59

227.06

4.5

4.0

1.8

mmol/l

0.29

5483

20789

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14790

65622

1.39

226.39

1.8

1.7

1.2

mg/l

0.42

11233

49965

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6714

25475

1.58

225.16

4.5

3.9

5.9

5.8

kpa

3.37

6455

24795

(3012544) pH of Venous blood

6896

26414

1.57

221.90

4.4

3.9

7.4

0.36

140

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10813

45535

1.45

221.17

3.2

2.8

2.9

2.7

e6/l

1.07

5919

24502

(3014576) Chloride [Moles/volume] in Serum or Plasma

8726

35221

1.50

221.11

7.7

7.2

104.1

104.6

mmol/l

15.02

8513

34492

(3035350) Ketones [Presence] in Urine by Test strip

29791

147250

1.31

219.89

4.1

3.4

0.0

estimate

1.23

5881

26974

(3009261) Glucose [Presence] in Urine by Test strip

30123

149175

1.31

218.84

4.1

3.4

0.0

estimate

1.18

5839

26803

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3903

12901

1.80

218.26

4.6

4.5

24.1

mmol/l

0.20

3501

11610

(3021601) Nitrite [Presence] in Urine by Test strip

29824

147609

1.31

216.79

5.4

4.6

0.0

estimate

0.86

6032

27671

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

596

718

4.83

214.35

2.4

2.5

150.4

150.6

nmol/l

0.01

512

634

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

685

936

4.26

213.79

2.2

1.8

127.3

135.7

umol/l

0.22

339

462

(3022217) INR in Platelet poor plasma by Coagulation assay

8828

35997

1.48

212.02

23.6

23.2

1.4

1.3

inr

0.69

1113

5337

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10401

43837

1.44

210.57

2.2

2.1

29.8

0.27

10054

42617

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11404

49038

1.42

206.34

3.0

2.7

1.3

1.1

e6/l

0.47

6487

27802

(3000764) Benzodiazepines [Presence] in Urine

3471

11253

1.83

206.29

3.7

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1077

2095

3.00

204.80

1.7

1.4

1.5

1.4

promille

1.06

833

1618

(3028300) Cannabinoids [Presence] in Urine

3483

11355

1.82

203.27

3.8

1.7

—

(3019060) Gas panel - Arterial blood

4923

17717

1.66

203.11

5.2

4.8

—

(3027008) Opiates [Presence] in Urine

3466

11326

1.81

200.69

3.7

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

19899

93873

1.32

199.55

2.7

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

18864

88483

1.32

196.07

4.0

10.2

9.1

mg/mmol

1.63

11749

56689

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7880

31884

1.49

195.17

4.1

4.2

237.6

244.1

u/l

3.30

7412

30211

(3042517) Benzodiazepines panel - Urine

310

188

9.57

195.06

3.3

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4813

17460

1.64

192.06

3.9

3.5

5.2

5.1

kpa

1.34

4486

16111

(3012516) Albumin [Mass/volume] in Urine

17985

84021

1.33

191.14

3.3

506.1

387.8

mg/l

2.18

11290

53679

(3009343) pH of Capillary blood

4748

17241

1.64

188.60

3.9

3.5

7.4

0.20

666

2212

(3023520) Reticulocytes [#/volume] in Blood

5845

22355

1.56

187.31

2.6

2.7

71.5

69.0

e9/l

4.90

4370

16875

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

54520

295733

1.37

185.30

5.1

4.2

6.0

5.9

mmol/l

53.48

49967

272511

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4598

16644

1.64

184.73

3.8

3.5

1.7

1.6

mmol/l

0.34

3395

12211

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2935

9348

1.85

183.93

2.4

2.3

529.8

543.1

ug/l

0.06

2741

8753

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1911

5220

2.15

183.13

1.5

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5765

22221

1.55

178.03

3.0

2.8

200.1

199.1

ng/l

0.05

5249

20136

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4448

16134

1.64

176.98

1.6

1.5

—

(3027944) Amphetamines [Presence] in Urine

3339

11198

1.76

176.83

3.5

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4319

15553

1.65

176.76

1.8

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

5458

20873

1.56

174.30

3.7

3.3

4.8

4.6

kpa

4.98

5202

20246

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4021

14318

1.66

171.62

9.0

9.9

24.3

mmol/l

0.41

3741

13383

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2513

7778

1.90

171.58

1.4

276.4

274.5

ug/g

0.14

1450

4481

(3007164) IgA [Mass/volume] in Serum or Plasma

12787

57562

1.35

170.93

1.5

1.4

2.4

g/l

0.92

7627

36014

(3026493) Urate [Moles/volume] in Serum or Plasma

16901

79272

1.31

170.35

2.8

2.5

3470.8

4256.0

umol/l

1.92

14525

69600

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4615

17051

1.61

170.31

6.8

7.6

24.8

24.7

mmol/l

1.55

4577

16896

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

28281

141726

1.27

169.91

4.3

3.9

—

(3048689) Calprotectin [Mass/mass] in Stool

8666

36634

1.42

168.66

2.3

2.4

137.3

131.1

ug/g

0.64

6792

29017

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14404

66132

1.33

168.40

1.3

1.8

u/ml

4.53

3693

18494

(3000494) Fungus identified in Specimen by Culture

8120

34001

1.43

166.26

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5286

20291

1.55

165.61

4.0

94.3

91.0

ng/l

1.29

4603

17600

(3013512) EKG study

17415

82299

1.30

165.01

4.2

3.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5651

22095

1.52

162.76

2.7

2.5

66.3

66.7

g/l

3.41

5121

20177

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6964

28445

1.46

162.19

4.0

3.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

16435

77287

1.30

160.58

1.7

1.6

1.5

1.4

mmol/l

44.06

13885

65301

(3022145) Colonoscopy Study observation

7874

32978

1.43

160.56

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1223

15269

0.45

160.32

1.4

1.5

—

(3003181) Sodium [Moles/volume] in Urine

1536

4068

2.21

158.46

1.4

59.5

64.9

mmol/l

4.97

1193

3229

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4545

17047

1.58

157.04

7.7

7.1

24.8

24.5

mmol/l

3.67

4260

15865

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

53318

289909

1.32

156.97

16.8

11.8

81.9

83.1

ml/min/173m2

33.17

44942

238962

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

669

1178

3.31

148.86

2.0

1.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5761

23136

1.48

145.07

2.5

2.1

12.8

12.5

nmol/l

1.60

5019

20707

(3011397) Hemoglobin [Presence] in Urine by Test strip

14558

68148

1.30

144.18

3.9

3.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15111

71163

1.29

142.78

2.6

2.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4784

18556

1.53

142.00

3.2

3.4

4.4

4.5

pmol/l

15.61

4174

16698

(3025941) Bacteria identified in Stool by Culture

4435

16985

1.55

139.31

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

4632

17978

1.53

136.87

2.5

2.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4500

17368

1.53

136.39

9.2

9.5

1.5

1.4

5.68

4472

17249

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3974

14944

1.57

135.04

9.6

10.0

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4488

17354

1.53

134.82

9.3

9.6

0.7

0.37

4462

17246

(3014007) Fractional oxyhemoglobin in Arterial blood

4499

17432

1.53

133.86

9.4

9.6

93.6

94.0

4.87

4477

17376

(3005719) IgG [Mass/volume] in Serum or Plasma

5445

21996

1.47

132.48

2.7

2.6

10.4

10.6

g/l

2.56

4964

20172

(21494755) Public health laboratory ask at order entry panel

4315

36294

0.67

132.35

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

13610

63773

1.29

131.75

4.5

3.7

1.0

kg/l

0.49

1909

9726

(40768804) Tissue Pathology biopsy report

24554

123398

1.24

131.70

2.2

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

8166

35629

1.37

128.83

1.8

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5607

22906

1.45

128.58

4.5

3.7

1.2

mmol/l

1.41

4886

20085

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3341

12194

1.61

128.35

1.7

1.6

1.5

g/l

1.95

2867

10401

(3037522) Nuclear Ab [Titer] in Serum

9363

41805

1.34

127.23

1.4

1.3

472.9

551.1

titre

3.73

1825

8396

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1816

5682

1.87

119.49

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1815

5681

1.87

119.29

1.4

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

5887

24594

1.42

119.18

4.4

4.1

1.0

0.9

0.31

1752

6690

(4010399)

5070

20599

1.46

119.15

1.5

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

16297

79034

1.25

116.67

4.6

3.8

0.0

estimate

0.36

5802

26515

(3022313) Gas panel - Capillary blood

3347

12512

1.58

116.13

4.0

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

14266

68211

1.27

114.87

5.1

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2205

7454

1.73

112.67

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

732

1611

2.64

111.86

1.8

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

785

10116

0.44

111.18

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

4267

17021

1.48

109.67

1.9

1.8

1.3

g/l

0.91

3878

15572

(3002179) Metamyelocytes/100 leukocytes in Blood

5355

22344

1.42

108.59

4.2

3.9

0.7

0.16

1263

4839

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

707

1560

2.64

107.52

3.2

2.7

20.9

26.5

ug/l

—

(3010421) pH of Blood

2148

7305

1.72

107.41

4.3

3.8

7.4

0.97

1833

6222

(3021440) Promyelocytes/100 leukocytes in Blood

5550

23454

1.40

104.50

4.5

4.1

0.1

0.16

1603

6221

(3019225) pH of Specimen

6378

27589

1.37

104.45

4.7

4.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

582

1176

2.88

103.87

1.9

1.5

2674996.9

1348111.1

iu/ml

1.48

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2040

6902

1.73

103.84

3.1

2.9

24.6

mmol/l

0.05

1813

6049

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5539

23433

1.40

103.58

2.5

2.2

6.8

7.7

ug/l

1.91

4766

20559

(1616796) Gas panel - Central venous blood

1881

6240

1.76

102.45

3.8

3.5

—

(3025159) Blasts/100 leukocytes in Blood

5246

22146

1.40

99.10

4.6

4.1

0.1

0.2

0.80

1373

5249

(42529406) Shigella sp [Presence] in Stool by Culture

2330

8290

1.65

98.50

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2307

8194

1.65

98.18

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2322

8274

1.65

97.58

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22642

115317

1.21

96.74

4.3

3.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

530

7543

0.40

96.32

1.4

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

59075

330045

1.32

95.97

21.2

14.6

78.2

76.8

umol/l

15.88

59059

329862

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2488

9062

1.61

95.82

2.6

—

(3008295) Osmolality of Serum or Plasma

918

2421

2.21

95.60

1.5

279.4

280.3

mosm/kgh2o

0.43

690

1917

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6521

28687

1.35

95.36

4.0

20.5

26.4

ug/l

0.89

5328

22796

(3002385) Erythrocyte distribution width [Ratio]

47514

259137

1.21

94.55

22.9

15.3

13.8

13.6

71.74

46690

253728

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

59221

331119

1.32

93.79

13.1

9.5

27.7

26.7

u/l

10.76

57429

320296

(3052851) Hemolysis interference index of Serum or Plasma

2359

8525

1.62

93.74

3.5

3.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1872

6366

1.72

93.51

4.3

3.9

5.0

kpa

1.76

1834

6216

(3012501) Base excess in Blood by calculation

1871

6365

1.72

93.34

4.3

3.8

2.5

mmol/l

0.26

1307

4248

(3027315) Oxygen [Partial pressure] in Blood

1880

6406

1.72

93.24

4.3

3.9

8.6

8.7

kpa

0.99

1842

6255

(3028626) Oxygen [Partial pressure] in Capillary blood

1871

6390

1.71

92.03

3.3

8.3

8.4

kpa

1.59

1749

5933

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

243

280

5.03

91.83

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11136

52908

1.26

91.35

1.3

37.6

34.8

iu/ml

0.23

3355

16803

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1823

6206

1.72

90.70

1.7

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

695

8681

0.46

90.24

1.3

1.5

—

(3047181) Lactate [Moles/volume] in Blood

2372

8668

1.60

90.06

6.3

5.7

1.3

mmol/l

1.11

2104

7646

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2856

10957

1.53

87.84

4.4

3.8

24.8

mmol/l

0.04

2670

10148

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1864

6442

1.69

87.81

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

1740

5907

1.72

87.41

2.7

2.4

16.5

16.6

0.17

932

3033

(3021901) Oxygen saturation in Capillary blood

1525

5022

1.77

85.06

2.8

—

(3024928) Oxygen saturation in Venous blood

1677

5697

1.72

84.03

3.4

3.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1538

5102

1.76

83.69

1.7

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3610

14681

1.45

83.29

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2605

9910

1.54

83.16

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2784

10755

1.52

82.84

2.2

2.0

2.3

2.1

ug/l

0.22

2466

9499

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2641

10097

1.53

82.43

2.5

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2636

10081

1.53

82.15

2.5

2.2

3.8

g/l

1.01

1897

7176

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2641

10112

1.53

81.87

2.5

2.2

7.3

7.4

g/l

0.62

1967

7548

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

672

8205

0.47

81.81

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

672

8201

0.47

81.70

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

671

8184

0.47

81.44

1.3

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

2517

9554

1.54

81.12

4.6

4.2

1.4

mmol/l

0.83

2469

9390

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1836

6461

1.66

80.81

2.1

1.9

200.3

197.6

pmol/l

0.45

1726

6151

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2501

9488

1.54

80.80

2.5

2.2

3.0

3.1

g/l

0.24

1932

7381

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

671

8154

0.47

80.59

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2479

9413

1.54

79.76

2.4

2.2

10.0

10.3

g/l

2.90

2051

7891

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7674

35425

1.29

78.35

8.1

6.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2243

8391

1.56

77.02

1.8

1.7

—

(3028271) Lactate [Moles/volume] in Capillary blood

1336

4365

1.79

76.49

2.1

1.8

1.7

1.8

mmol/l

0.83

1309

4258

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2271

8535

1.56

76.43

2.5

2.4

0.8

0.9

g/l

0.76

1928

7362

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10389

49875

1.24

75.99

1.3

10.2

11.7

u/ml

1.13

3792

20089

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

507

6682

0.43

75.94

1.7

1.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3183

12893

1.45

74.80

3.5

2.9

1.4

1.3

5.81

3164

12828

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

358

5396

0.38

74.38

1.3

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3987

16846

1.39

74.04

3.9

3.4

128.3

129.9

g/l

4.22

3889

16465

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2390

9164

1.53

73.50

3.3

3.1

0.3

u/ml

1.66

1358

5189

(3016650) Hepatitis A virus Ab [Presence] in Serum

1418

4774

1.73

73.32

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2393

9196

1.52

72.83

1.9

1.7

40.0

41.0

nmol/l

1.31

2316

8992

(3007566) Smooth muscle Ab [Titer] in Serum

2178

8203

1.55

72.58

1.2

121.0

123.2

titre

0.03

203

746

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

19040

97316

1.18

72.21

5.0

4.6

2.8

3.3

ug/l

1.76

16870

87911

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2083

7783

1.56

71.86

2.3

2.2

37.7

37.8

g/l

0.52

1786

6697

(36660697) Celiac disease serology panel - Serum

5307

23562

1.33

71.75

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3103

12631

1.44

70.96

3.5

2.9

0.7

0.98

2986

12115

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2029

7574

1.57

70.27

2.4

2.2

0.0

g/l

0.31

1830

6949

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1765

6377

1.62

70.03

2.2

2.1

130.2

131.2

g/l

0.81

1277

4674

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1895

6972

1.59

69.80

2.4

2.3

0.0

g/l

0.25

1700

6371

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2162

8229

1.54

68.70

3.8

3.1

47.2

42.3

mg/l

0.35

1747

6644

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2111

7994

1.54

68.64

3.7

3.1

5.9

2.8

ratio

0.53

180

622

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2832

11404

1.46

68.51

5.7

4.9

1.8

1.7

5.37

2642

10707

(3043238) Trisomy 21 risk [Likelihood] in Fetus

569

6913

0.47

68.25

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1683

6048

1.62

68.23

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1866

6884

1.58

67.94

2.4

2.3

0.0

g/l

0.00

1694

6355

(3034860) Kappa light chains.free [Mass/volume] in Serum

2160

8244

1.53

67.78

3.8

3.1

54.6

64.4

mg/l

0.50

1746

6652

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1386

4750

1.70

67.27

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1121

3623

1.80

66.53

6.2

11.4

mg/l

0.08

1020

3341

(3039000) Anion gap in Blood

1682

6082

1.61

66.51

7.2

6.7

11.2

11.3

mmol/l

0.54

1524

5475

(3018572) Chloride [Moles/volume] in Blood

1682

6083

1.61

66.47

7.2

6.7

104.8

105.2

mmol/l

2.62

1524

5477

(40761511) CBC panel - Blood by Automated count

57877

324674

1.24

66.17

17.5

11.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

556

6736

0.47

66.15

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

556

6725

0.47

65.84

1.3

1.4

—

(3023419) Bacteria identified in Sputum by Culture

1030

3254

1.84

65.74

2.5

2.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3053

12577

1.42

65.32

1.5

14.0

14.3

u/ml

0.03

347

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1353

4644

1.70

65.31

1.8

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

2112

8093

1.53

65.06

1.2

771.6

989.0

titre

0.78

246

(3007930) Methemoglobin/Hemoglobin.total in Blood

2763

11222

1.44

63.82

5.7

4.9

0.9

1.59

2580

10535

(3016038) Potassium [Moles/volume] in Urine

587

1529

2.23

63.11

1.2

32.7

35.1

mmol/l

1.51

494

1333

(3020891) Body temperature

2707

11009

1.44

62.07

5.7

4.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

16032

81609

1.18

61.56

3.7

3.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1365

4777

1.67

61.32

1.5

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

174

216

4.67

60.95

7.1

7.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1605

5867

1.60

60.70

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1613

5906

1.59

60.59

5.8

5.9

3411.1

1249.4

iu/ml

0.36

229

891

(3043409) Potassium [Moles/volume] in Arterial blood

2124

8304

1.49

59.49

5.0

4.5

3.9

mmol/l

1.40

1972

7827

(3037756) Immunofixation for Serum or Plasma

1493

5403

1.61

58.84

1.8

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4327

32093

0.76

57.47

1.8

1.7

—

(3007463) Buprenorphine [Presence] in Urine

103

7.85

57.21

9.5

5.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2811

11691

1.41

56.87

1.1

1.2

11.3

u/ml

2.07

183

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5075

23100

1.29

56.61

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1650

6172

1.56

56.59

3.9

3.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

1054

3567

1.72

53.57

2.0

1.8

89.2

90.0

3.93

1041

3512

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1076

3665

1.71

53.44

1.6

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1704

6504

1.53

53.41

1.4

29.4

30.5

e6/l

0.04

1336

5015

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1705

6510

1.53

53.36

1.4

1.5

1435.3

2331.2

e6/l

0.58

1412

5272

(1002224) Polysomnography panel

3127

13405

1.37

52.72

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1165

4082

1.66

52.14

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1254

4483

1.63

51.92

2.8

2.9

8763.8

5326.7

u/ml

0.17

242

(3026389) Candida sp identified in Specimen by Organism specific culture

1158

4056

1.66

51.90

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1885

7401

1.49

51.68

1.3

523.1

548.9

mg/l

0.58

1797

7068

(3035637) Corticotropin [Mass/volume] in Plasma

1043

3558

1.71

51.54

1.5

1.6

—

(40761535) Cells panel - Urine sediment

5115

23577

1.28

51.46

3.8

3.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3494

15301

1.34

51.26

3.2

2.6

0.3

e6/l

0.04

3399

14872

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2403

9916

1.42

50.76

1.6

213.1

294.3

titre

0.96

415

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

55588

311971

1.19

50.68

5.3

4.6

2.7

2.8

mmol/l

124.80

51315

290138

(3009214) Lutropin [Units/volume] in Serum or Plasma

2217

9032

1.43

50.25

1.4

9.8

10.1

u/l

0.47

1764

7427

(40761536) Microorganisms panel - Urine sediment

5432

25318

1.26

49.78

4.6

3.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

751

2346

1.86

49.75

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1593

6102

1.52

49.12

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1026

3535

1.69

48.92

1.4

—

(3049717) Cytology report of Urine Cyto stain

2516

10557

1.39

48.26

2.6

2.7

—

(3044290) Cell count panel - Cerebral spinal fluid

1585

6120

1.51

47.09

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4350

19879

1.28

46.70

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1971

7985

1.44

46.02

1.5

18.2

13.9

iu/ml

0.48

187

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2782

11963

1.36

45.90

1.2

0.8

u/ml

0.02

241

1053

(3021387) Prolactin [Units/volume] in Serum or Plasma

2572

10932

1.37

45.63

1.7

348.1

298.6

mu/l

4.95

2297

9928

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1663

6531

1.48

45.54

1.2

1.3

3.8

3.7

mmol/l

0.98

1546

6154

(3027273) Bicarbonate [Moles/volume] in Venous blood

3070

13440

1.34

45.02

4.1

3.4

25.3

25.2

mmol/l

0.48

2974

13031

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

251

3535

0.41

44.56

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

771

2526

1.77

43.90

3.0

2.7

—

(4035726)

5396

25488

1.24

43.73

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2595

11124

1.36

43.65

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2281

9586

1.39

43.32

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

54643

307057

1.16

42.78

4.8

4.2

4.6

4.7

mmol/l

79.74

50586

287373

(44806118)

882

3031

1.69

42.52

1.6

—

(44790049)

882

3032

1.69

42.47

1.6

—

(44790048)

882

3033

1.69

42.42

1.6

—

(44790047)

882

3033

1.69

42.42

1.6

—

(40768443) Skin Pathology biopsy report

2923

12827

1.33

42.14

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2159

9036

1.39

42.01

1.7

0.2

g/l

0.50

2052

8565

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2859

21522

0.76

41.80

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

896

3109

1.68

41.69

17.0

5.6

7.6

7.3

mmol/l

0.60

751

2533

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1048

3790

1.61

41.51

1.5

1.4

—

(3017732) Neutrophils [#/volume] in Blood

4529

21094

1.26

41.44

3.5

2.6

4.1

e9/l

0.10

3493

16564

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

52550

294603

1.15

41.39

4.3

3.8

1.4

1.3

mmol/l

194.40

48049

273243

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2210

9322

1.38

41.04

1.7

1.2

g/l

0.63

2106

8870

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1921

7920

1.41

40.75

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1917

7907

1.41

40.56

3.5

3.6

1.6

1.5

mg/l

4.61

1767

7300

(3004809) Band form neutrophils/100 leukocytes in Blood

1200

4521

1.54

39.95

3.2

1.5

1.4

0.20

949

3482

(3042631) Mycobacterium sp identified in Specimen

1012

3666

1.61

39.83

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2708

11856

1.33

39.63

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2497

10800

1.35

39.63

2.0

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

873

3055

1.66

39.37

1.7

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2874

12704

1.32

39.36

2.0

39.0

39.4

u/l

0.42

2538

11377

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1362

5297

1.50

39.14

3.5

3.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

4167

19346

1.26

39.11

1.4

1.3

247.6

234.5

u/ml

0.18

3833

17991

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14887

77461

1.14

39.08

4.4

4.0

21.7

22.0

1.33

6535

36394

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1174

4427

1.54

38.94

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

748

2520

1.72

38.77

3.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

54217

304949

1.15

38.68

4.8

4.1

1.4

1.5

mmol/l

35.34

49969

284201

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

838

2915

1.67

38.67

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3545

16159

1.28

38.63

1.4

1.3

28.4

28.2

iu/l

0.11

3009

14027

(3019230) Fractional oxyhemoglobin in Venous blood

1250

4788

1.52

38.61

3.6

3.2

63.7

65.2

1.51

1242

4767

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

978

3556

1.60

37.93

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

998

3650

1.59

37.78

1.5

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2305

9923

1.36

37.70

3.4

3.5

2089.4

1788.8

u/ml

0.09

1977

8527

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2803

12445

1.32

37.19

4.6

3.8

51.0

47.9

8.08

2762

12313

(3024522) Salmonella sp identified in Specimen by Organism specific culture

976

3568

1.59

37.03

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

636

2073

1.78

36.94

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

966

3526

1.59

36.89

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

963

3522

1.59

36.48

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

963

3524

1.59

36.39

1.5

1.4

—

(3036180) Methadone [Presence] in Urine

10.95

36.28

3.2

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4465

21074

1.24

36.17

2.4

24.9

23.0

au/ml

0.45

254

1302

(3037121) Protein [Mass/volume] in Urine

2272

9831

1.35

35.94

3.3

3.2

0.3

g/l

0.17

1060

4417

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

927

3381

1.59

35.53

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

6.88

34.90

1.4

433.6

579.4

nmol/l

0.86

(3051651) Icteric interference index of Serum or Plasma

520

1637

1.84

33.83

4.1

3.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

964

3592

1.56

33.76

1.6

—

(3002256) Pathology report gross observation

7909

39651

1.17

33.72

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3383

15588

1.27

33.71

1.1

—

(3019977) pH of Arterial blood

473

1449

1.89

33.45

2.8

2.4

7.4

0.02

153

516

(3023410) Appearance of Cerebral spinal fluid

823

2961

1.61

33.39

1.5

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

756

2670

1.64

33.01

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

3277

15094

1.27

32.74

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

774

2756

1.63

32.74

1.6

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4071

19274

1.24

31.94

1.3

45.0

49.4

au/ml

0.53

158

807

(3030905) Polymorphonuclear cells [#/volume] in Blood

1460

5989

1.42

31.91

3.5

3.3

4.2

4.1

e9/l

0.76

1453

5981

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4990

24125

1.21

31.90

2.8

2.6

66.8

67.1

ml/min/173m2

0.18

2041

9368

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

566

1868

1.76

31.62

1.2

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

11055

57083

1.14

31.43

2.0

1.8

—

(1761868) Lipid panel - Serum or Plasma

18852

117730

0.90

31.34

3.0

2.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4391

21037

1.22

30.72

1.2

112.7

148.5

iu/ml

8.10

1527

8129

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

395

1174

1.95

30.56

2.6

2.4

57.2

52.9

umol/l

1.62

326

978

(3036489) Thrombin time

2538

11433

1.29

30.23

2.1

21.4

21.5

0.36

2240

9895

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2065

9047

1.33

30.07

2.7

3.6

g/l

0.03

1951

8649

(3024980) IgG subclass 4 [Mass/volume] in Serum

1206

4845

1.45

29.54

1.5

1.6

0.7

0.8

g/l

1.13

924

3630

(3044242) Glucose [Moles/volume] in Arterial blood

399

1206

1.92

29.44

2.1

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

553

1859

1.73

29.04

2.0

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

329

941

2.03

28.35

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

659

2341

1.63

28.22

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

659

2341

1.63

28.22

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

659

2341

1.63

28.22

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1533

6487

1.37

27.98

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

180

2393

0.43

27.86

1.5

1.6

8.4

7.7

mmol/l

2.13

102

1459

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1144

4607

1.44

27.70

3.0

3.1

0.8

nmol/l

0.14

849

3547

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1224

4996

1.42

27.55

1.4

1.3

27.1

27.0

u/l

0.03

967

4140

(3023199) Leukocytes [#/volume] in Pleural fluid

820

3092

1.54

27.36

1.5

3983.1

3075.7

e6/l

0.32

609

2241

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1022

4043

1.47

27.14

1.3

0.2

0.3

nmol/l

2.74

240

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1024

4053

1.47

27.13

1.3

1.1

1.2

nmol/l

0.12

982

3913

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1086

4349

1.45

27.09

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

805

3036

1.54

26.85

3.5

3.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1605

6889

1.36

26.81

1.6

14502.0

13185.2

e6/l

0.47

1134

5052

(3013005) Retinol [Moles/volume] in Serum or Plasma

378

1161

1.89

26.66

1.7

1.8

2.0

umol/l

0.55

354

1092

(3003434) Protein [Mass/volume] in Pleural fluid

894

3457

1.50

26.57

1.4

1.5

33.3

33.1

g/l

0.14

815

3104

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4805

32595

0.84

26.51

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

801

3028

1.54

26.44

1.2

63.9

63.2

u/l

0.05

546

2042

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

914

3565

1.49

26.06

2.1

1.8

3936.6

4007.5

titre

0.02

150

(3045414) Leukocytes [Presence] in Urine

2819

13117

1.25

25.79

2.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10727

55912

1.13

25.75

3.0

2.9

0.7

0.8

ug/l

12.13

7118

35666

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1362

5735

1.38

25.65

1.3

1.2

203.8

111.9

titre

0.43

114

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

119

218

3.16

25.41

1.3

1.2

53.1

44.3

mg/l

0.90

(3011985) Renin [Units/volume] in Plasma

992

3958

1.46

25.26

1.5

1.6

64.4

66.3

mu/l

0.10

852

3580

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.89

25.24

1.7

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

499

1699

1.70

25.13

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

696

2579

1.57

25.12

2.2

42.0

40.2

0.48

336

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

490

1668

1.70

24.71

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1831

8119

1.31

24.54

2.0

2.1

11.1

10.8

mg/l

0.76

1696

7616

(3017950) Salicylates [Moles/volume] in Serum or Plasma

6.94

24.52

1.6

1.2

1173.7

2144.4

umol/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

596

2146

1.61

24.27

2.4

2.6

718.7

724.3

e6/l

0.03

220

883

(3028308) Erythrocytes [#/volume] in Pleural fluid

738

2803

1.53

23.91

1.5

73974.9

52275.0

e6/l

0.73

451

1680

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2076

9408

1.28

23.63

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

827

3228

1.49

23.56

1.5

—

(3017569) Oxygen content in Arterial blood

371

1181

1.82

23.51

2.2

2.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1405

6031

1.35

23.51

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

727

2763

1.53

23.49

3.1

3.2

58.1

58.8

0.36

482

1766

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

535

1892

1.64

23.42

1.4

12.4

12.7

u/l

0.60

514

1832

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

549

1955

1.63

23.39

1.8

1.7

—

(3000492) Spirometry study

5999

30234

1.16

23.38

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1072

4404

1.41

23.36

4.1

3.4

33.4

37.2

u/ml

0.43

1034

4243

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

273

785

2.01

23.31

3.1

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

273

785

2.01

23.31

3.1

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1328

5669

1.36

23.03

1.3

282.0

268.8

u/ml

0.91

899

3679

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7034

35909

1.15

22.95

4.7

4.3

31.7

32.0

1.37

4875

25283

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

358

1136

1.83

22.93

2.9

—

(3011412) CD3 cells [#/volume] in Blood

745

2862

1.51

22.92

2.4

1.2

e9/l

0.38

437

1712

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

919

3686

1.45

22.82

1.3

—

(4062490)

790

3084

1.49

22.51

1.4

—

(3045788) Cell count panel - Pleural fluid

637

2376

1.56

22.41

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

788

3078

1.49

22.40

1.3

1.4

2.8

3.0

g/l

2.52

568

2121

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

327

1017

1.86

22.32

2.8

2.9

28.8

28.6

umol/l

0.14

237

782

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

641

2397

1.55

22.31

1.2

121.0

193.1

titre

2.05

101

393

(3024139) IgG subclass 3 [Mass/volume] in Serum

787

3077

1.48

22.27

1.3

1.4

0.4

g/l

1.75

568

2129

(3051611) Lipemic interference index of Serum or Plasma

757

2937

1.50

22.24

3.9

3.3

—

(3044941) Cell count panel - Synovial fluid

1062

4399

1.40

22.11

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1109

4629

1.39

22.08

1.5

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

787

3083

1.48

22.06

1.3

1.4

6.5

6.8

g/l

1.09

565

2125

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

638

2391

1.55

22.00

1.2

270.5

132.9

titre

0.71

(21494890) Protein electrophoresis panel - 24 hour Urine

724

2790

1.51

21.97

2.5

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

353

1131

1.81

21.96

2.6

2.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

6271

31857

1.15

21.87

2.1

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

857

3421

1.45

21.85

2.3

2.0

23.4

26.3

mg/l

0.76

227

921

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1422

6198

1.33

21.54

1.2

38.3

43.9

u/ml

0.57

134

628

(3006922) Hepatitis E virus Ab [Presence] in Serum

569

2090

1.58

21.42

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6923

35465

1.14

21.39

2.2

2.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

386

1283

1.74

21.27

28.6

28.2

116.2

117.5

ug/l

0.13

320

1061

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

175

2121

0.48

21.20

1.3

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

835

3341

1.45

21.05

1.9

27.0

23.6

ug/l

0.55

813

3283

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2103

9688

1.26

20.98

2.2

2.4

91.8

92.2

0.28

1953

9021

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1936

8831

1.28

20.96

2.4

2.6

193.8

185.2

3.76

1817

8390

(3019832) Treponema pallidum Ab [Presence] in Serum

4525

30276

0.85

20.87

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

427

1470

1.68

20.77

1.6

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

971

4005

1.41

20.75

2.6

2.7

1174.0

624.5

u/ml

0.25

947

3834

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.21

20.57

1.7

1.6

316.7

263.8

nmol/l

0.18

(3029634) Reagin Ab [Titer] in Serum by VDRL

1030

4305

1.39

20.39

2.6

2.1

6.3

7.4

titre

0.16

120

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

348

1138

1.77

20.29

1.7

1.8

28.8

29.3

umol/l

0.40

341

1092

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

979

4060

1.40

20.29

1.1

1.5

g/l

1.06

875

3689

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1719

7757

1.29

20.27

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

428

1485

1.67

20.24

1.6

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

809

3243

1.45

20.22

3.1

3.3

5.8

7.8

nmol/l

0.52

779

3151

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

462

1637

1.64

20.17

1.3

1.2

27.6

23.9

u/l

0.65

389

1424

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

473

1688

1.62

20.08

1.3

1.2

93.7

91.0

u/l

0.19

402

1497

(40768806) Pleura Pathology biopsy report

689

2680

1.49

20.05

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

591

2227

1.54

19.95

1.1

293.5

422.6

mg/l

0.48

526

1999

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1415

6234

1.32

19.93

1.4

1.5

16.4

19.4

u/ml

0.40

118

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

898

3683

1.42

19.84

1.4

324.8

293.8

pmol/l

0.73

675

2878

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1047

4409

1.38

19.83

1.3

37.7

34.0

u/l

0.34

914

3842

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1638

7369

1.29

19.79

1.9

14.9

13.6

iu/l

0.06

575

2763

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.16

19.77

1.2

1.0

—

mmol/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1841

8408

1.27

19.75

1.3

40.4

35.3

u/ml

0.28

100

518

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1423

6287

1.32

19.65

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

662

2568

1.50

19.54

3.0

49.3

55.7

mg/l

0.21

468

1844

(3017315) Amylase [Enzymatic activity/volume] in Urine

443

1566

1.64

19.54

1.3

1.2

263.5

336.8

u/l

0.93

404

1472

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1292

5638

1.33

19.46

3.4

3.3

594.1

882.8

u/ml

0.68

1180

5108

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

471

1693

1.61

19.45

1.6

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

449

1601

1.63

19.15

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1990

9210

1.26

19.12

1.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

629

2426

1.50

19.10

1.7

2.2

17.7

18.3

nmol/l

0.97

573

2317

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

441

1568

1.63

19.03

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.23

18.82

1.5

1.6

257.1

241.5

nmol/l

0.07

(40757494) Bilirubin.total [Moles/volume] in Blood

415

1459

1.65

18.72

2.1

2.2

25.5

33.5

umol/l

0.48

139

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

505

1864

1.57

18.70

1.5

25.7

24.8

u/ml

0.13

381

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

754

3029

1.44

18.68

1.2

—

(3021788) Differential panel - Synovial fluid

1215

5289

1.33

18.63

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

609

2347

1.50

18.58

1.3

557.6

493.5

u/l

0.27

576

2222

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

381

1315

1.68

18.44

1.5

1.6

17.5

5.3

nmol/l

0.42

319

1099

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

500

1854

1.56

18.17

1.2

1.3

14.9

14.0

u/l

0.28

458

1718

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

371

1277

1.68

18.15

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

553

2099

1.53

18.12

2.0

2.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

371

1278

1.68

18.09

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

193

539

2.07

17.95

1.2

—

(3014271) Vancomycin [Susceptibility]

369

1276

1.68

17.76

3.0

2.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

607

2363

1.49

17.67

2.2

1.9

1.3

1.0

g/24h

0.25

137

(3044927) Protein electrophoresis panel - Urine

660

2613

1.46

17.67

1.3

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

645

2543

1.47

17.64

4.5

3.5

40.9

49.8

u/ml

0.56

636

2516

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

321

1070

1.74

17.62

2.6

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1583

7199

1.28

17.62

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

511

1921

1.54

17.51

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

361

1246

1.68

17.50

3.8

—

(4094501)

1746

8053

1.26

17.31

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

187

525

2.06

17.18

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

540

2064

1.52

17.17

2.4

2.6

518.5

535.8

e6/l

0.27

435

1742

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

511

1932

1.53

17.08

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

396

1411

1.63

17.01

1.6

1.5

22.5

25.6

umol/l

1.20

374

1347

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1296

5776

1.30

16.87

1.5

111.8

u/ml

0.00

284

1331

(3035947) Staphylolysin Ab [Units/volume] in Serum

399

1428

1.62

16.85

1.2

1.1

3.6

4.1

iu/ml

0.40

118

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1692

7801

1.26

16.84

1.3

6.7

8.1

u/ml

0.45

240

1248

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

441

1621

1.58

16.69

1.3

485.3

447.8

titre

0.06

116

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

294

972

1.75

16.64

1.4

14.5

15.0

pmol/l

0.66

238

824

(3012441) Differential panel - Pleural fluid

672

2707

1.44

16.48

1.4

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

793

3291

1.40

16.48

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

453

1683

1.56

16.39

2.7

2.8

38.6

39.3

0.20

146

567

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1084

4736

1.33

16.28

1.5

1.4

0.3

0.4

nmol/l

3.99

834

3696

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

592

2335

1.47

16.21

1.3

1.2

2.1

mmol/l

0.12

546

2172

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

515

1974

1.51

16.20

1.3

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1132

4981

1.32

16.18

1.6

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

653

2626

1.44

16.17

1.3

1.5

1.4

nmol/l

0.44

584

2378

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

428

1575

1.57

16.15

1.3

73.1

77.7

titre

0.10

136

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

452

1686

1.55

16.09

1.1

3.5

5.2

nmol/l

0.33

344

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1662

7692

1.26

16.03

1.3

6.8

5.8

u/ml

0.15

139

835

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

301

1015

1.72

15.93

1.3

1.5

72.2

72.8

0.27

284

968

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

296

994

1.72

15.90

1.4

1.5

677.7

739.5

mu/l

0.15

279

947

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

516

1989

1.50

15.82

1.3

1.2

—

(3017704) Immunofixation for Urine

392

1421

1.60

15.76

1.8

1.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

577

2281

1.47

15.64

2.0

2.1

73.8

72.5

1.29

545

2202

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

233

733

1.84

15.55

1.3

118.2

128.8

nmol/l

0.52

176

545

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2406

11616

1.20

15.52

1.7

3.6

3.5

mg/l

0.29

1857

8059

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1843

8665

1.24

15.46

1.1

3.7

5.7

u/ml

1.64

187

1218

(3020961) Endomysium IgA Ab [Titer] in Serum

2960

14568

1.18

15.41

1.1

156.9

211.9

titre

0.79

387

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1739

8129

1.24

15.38

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

759

3169

1.39

15.27

1.1

11.5

72.7

au/ml

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

694

2854

1.41

15.24

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

515

2001

1.49

15.22

2.4

2.6

0.2

e9/l

0.00

435

1734

(3036782) Glucose [Moles/volume] in Pleural fluid

614

2473

1.44

15.12

1.3

6.4

6.3

mmol/l

0.49

559

2294

(3017509) Phencyclidine [Presence] in Urine

124

310

2.31

15.11

2.2

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

205

625

1.90

15.06

1.3

1.2

—

(3022621) pH of Urine by Test strip

3822

19248

1.16

14.89

3.1

2.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

565

2250

1.46

14.78

2.0

2.1

14.0

14.3

0.15

266

1051

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

412

1541

1.55

14.55

1.8

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

50890

288761

1.08

14.39

20.4

13.5

39.7

40.1

22.69

35845

216653

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

864

1.73

14.07

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

877

3798

1.34

14.06

1.7

1.5

—

(3010503) CD19 cells [#/volume] in Blood

459

1774

1.50

13.97

2.7

2.6

0.2

0.4

e9/l

0.99

443

1734

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

461

1785

1.50

13.91

1.7

1.5

6.0

6.3

u/l

0.15

228

854

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1975

9466

1.21

13.78

1.6

14.5

4.9

iu/ml

0.46

433

1982

(3026250) Tacrolimus [Mass/volume] in Blood

370

1368

1.57

13.77

36.6

7.1

7.4

ug/l

2.86

334

1250

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

485

1902

1.48

13.76

3.0

3.4

138.2

129.2

nmol/l

0.20

474

1875

(3000012) Reticulocyte production index

394

1479

1.54

13.73

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1849

8816

1.22

13.60

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

382

1433

1.54

13.37

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

382

1433

1.54

13.37

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

382

1433

1.54

13.37

1.8

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

382

1435

1.54

13.29

1.8

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

308

1100

1.62

13.25

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

308

1101

1.62

13.21

2.0

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1362

6307

1.25

13.16

1.3

1.2

5.1

5.4

u/ml

0.05

502

(3023511) Choriogonadotropin [Units/volume] in Urine

1227

5617

1.27

13.07

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

406

1553

1.51

13.02

2.0

2.1

2.4

ug/l

0.43

342

1296

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

312

1124

1.61

12.98

1.1

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

1382

6425

1.25

12.91

2.2

2.1

—

(3004451) EKG impression Narrative

352

1309

1.56

12.83

1.3

1.2

—

(4024509)

603

2498

1.40

12.80

1.7

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

309

1117

1.60

12.69

2.0

2.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

244

830

1.70

12.65

2.2

1.8

7247.5

12679.0

e6/l

0.81

149

426

(3047189) Immunofixation for 24 hour Urine

324

1188

1.58

12.55

2.1

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

122

330

2.14

12.47

3.4

3.2

41.9

41.6

umol/l

0.05

108

279

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

537

2194

1.42

12.35

1.3

1.0

1.3

u/ml

0.39

274

937

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

448

1770

1.47

12.31

2.0

2.2

99.1

97.9

0.29

416

1659

(3045716) Anion gap in Serum or Plasma

333

1235

1.56

12.30

2.7

2.4

9.1

9.2

mmol/l

0.21

242

912

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1345

6277

1.24

12.17

1.2

4.7

15.5

u/ml

1.24

(3037692) Legionella sp identified in Specimen by Organism specific culture

267

942

1.64

12.11

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

530

2169

1.42

12.09

2.1

1.8

3.7

3.8

mg/l

0.04

501

2071

(3023487) Leukocytes [#/volume] in Peritoneal fluid

266

941

1.64

11.95

2.3

1.9

2378.2

3677.0

e6/l

0.26

185

636

(40768441) Liver Pathology biopsy report

525

2151

1.41

11.91

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6671

35247

1.10

11.82

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

551

2280

1.40

11.82

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

410

1606

1.48

11.79

1.9

2.0

3.2

3.7

ug/l

0.61

367

1401

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

223

756

1.71

11.75

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

637

2704

1.37

11.73

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

202

2.43

11.67

1.6

1.9

44.5

46.0

umol/l

0.19

202

(4146454)

699

3014

1.34

11.64

2.7

2.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

380

1472

1.50

11.55

1.3

58.6

62.8

0.37

176

(3045142) Bone marrow Pathology biopsy report

700

3024

1.34

11.52

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

220

749

1.70

11.43

1.3

1.4

—

(40757373) Influenza virus identified in Isolate

166

520

1.85

11.39

1.7

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

157

484

1.88

11.31

2.6

47.3

49.7

mg/l

0.05

(3028433) Virus identified in Specimen by Culture

262

938

1.62

11.26

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

531

4203

0.73

11.18

1.4

1.3

2.7

3.5

ug/l

2.54

441

3704

(3010838) Calcium [Moles/time] in 24 hour Urine

364

1408

1.50

11.16

1.6

4.4

6.0

mmol/24h

2.10

105

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

826

3675

1.30

11.08

1.5

1.6

56.8

57.5

0.19

524

2350

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

425

1700

1.45

11.03

1.1

u/l

0.13

185

773

(3033799) Differential panel - Peritoneal fluid

233

815

1.66

10.98

2.3

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

340

1302

1.51

10.95

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

105

284

2.14

10.81

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

339

1302

1.51

10.77

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

429

1731

1.44

10.65

1.4

6.1

5.9

u/l

0.09

354

1467

(3022493) Free Hemoglobin [Mass/volume] in Plasma

323

1231

1.52

10.65

5.0

5.1

645.4

2828.7

mg/l

1.86

250

865

(40768446) Kidney Pathology biopsy report

320

1218

1.52

10.61

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

145

447

1.88

10.49

1.3

1.2

1.4

1.7

mmol/l

2.22

279

(3035880) pH of Pleural fluid

360

1409

1.48

10.46

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

178

586

1.76

10.45

1.4

26.4

38.1

g/l

0.60

129

457

(3013762) Body weight Measured

3.01

10.36

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

241

865

1.61

10.30

1.6

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

840

3784

1.29

10.30

1.3

1.2

61.3

50.0

u/ml

0.54

242

(3052592) Norovirus Ag [Presence] in Stool

165

536

1.78

10.14

1.4

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

375

1494

1.45

9.99

8.4

5.7

987.9

3667.5

u/ml

0.58

118

280

(4015189)

205

712

1.67

9.98

2.3

2.2

—

(40762365) Oxygen content in Arterial blood by calculation

143

447

1.85

9.94

3.0

14.9

14.8

ml/dl

0.14

130

421

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

550

2346

1.36

9.92

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

241

2.18

9.90

2.1

2.0

1.3

umol/l

1.05

212

(4027681)

463

1924

1.39

9.80

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

584

2520

1.34

9.78

1.2

1.1

38.9

43.8

mg/l

1.39

488

2107

(3033923) Metanephrine [Moles/time] in 24 hour Urine

167

551

1.75

9.77

1.1

0.7

3.3

umol/24h

0.52

288

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

425

1743

1.41

9.70

1.0

274.1

346.2

ng/l

2.39

317

1229

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8900

48079

1.08

9.48

1.7

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

535

2291

1.35

9.43

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

619

2712

1.32

9.37

1.3

1.4

122944.9

98489.2

e6/l

0.41

414

1891

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

535

2296

1.35

9.31

1.1

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

425

1758

1.40

9.27

1.0

796.5

732.0

ng/l

2.05

299

1200

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

562

2432

1.34

9.26

1.1

259.5

272.2

mg/l

0.65

493

2136

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2994

15328

1.14

9.26

2.0

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

534

2294

1.35

9.24

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

538

2314

1.35

9.23

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

538

2315

1.35

9.21

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

425

1761

1.40

9.18

1.0

43.2

41.5

ng/l

0.13

309

1221

(3026692) Albumin [Mass/volume] in Peritoneal fluid

190

662

1.66

9.18

1.6

1.4

13.0

13.4

g/l

0.26

132

515

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

538

2318

1.34

9.14

1.1

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

261

984

1.54

9.13

1.8

1.6

46827.7

20117.5

u/ml

0.25

128

(3023420) DNA double strand Ab [Units/volume] in Serum

734

3304

1.29

9.12

1.6

1.5

24.1

35.2

iu/ml

1.91

150

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

344

1375

1.45

9.07

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

246

917

1.55

9.05

1.2

22.4

21.2

0.09

157

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

131

413

1.84

8.93

1.1

—

(21494434) Karyotype in Bone marrow

540

2341

1.34

8.82

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

126

394

1.85

8.82

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

783

0.46

8.79

3.2

3.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

782

0.46

8.76

6.4

6.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

200

716

1.62

8.73

1.4

1.3

16.6

17.0

umol/l

0.51

181

632

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

278

2.02

8.71

2.2

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

336

1348

1.44

8.71

3.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1264

6078

1.21

8.71

2.0

2.1

0.9

0.8

nmol/l

1.47

1036

5141

(3051593) INR in Capillary blood by Coagulation assay

318

1263

1.46

8.69

8.9

9.8

—

(3006245) CD3-CD19+ cells/100 cells in Blood

295

1155

1.48

8.66

1.9

2.2

9.2

10.5

1.32

271

1073

(21491868) Cryoglobulin [Mass/volume] in Serum

265

1016

1.51

8.61

1.3

1.2

0.7

0.4

g/l

0.33

(3029075) Extractable nuclear Ab panel - Serum

229

853

1.55

8.49

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1041

4934

1.22

8.32

1.1

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

218

2.12

8.21

1.3

11.3

14.8

pmol/l

0.49

180

(3006270) Folate [Moles/volume] in Blood

553

2433

1.32

8.20

1.2

374.6

368.3

nmol/l

0.29

470

2063

(3016244) Insulin [Units/volume] in Serum or Plasma

440

1871

1.36

8.19

2.7

3.5

27.9

28.2

mu/l

0.05

408

1775

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

288

1137

1.47

8.15

1.8

2.2

29.8

29.0

0.39

267

1080

(40761539) Cells [Type] in Urine sediment by Light microscopy

194

702

1.60

8.15

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

159

548

1.68

8.07

1.9

2.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

201

2.16

8.02

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

164

571

1.66

8.02

1.6

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

226

851

1.54

8.02

1.8

2.2

772.2

715.8

e6/l

0.03

122

457

(3044007) Cell count panel - Peritoneal fluid

206

760

1.57

7.99

2.1

1.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

365

1512

1.40

7.98

1.1

86.2

85.7

u/l

0.03

280

1214

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

249

2.02

7.89

1.1

1.2

—

(40768793) Breast Pathology biopsy report

1303

6344

1.19

7.89

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

234

2.05

7.83

1.6

1.9

mg/l

0.28

145

(3003694) ABO and Rh group [Type] in Blood

14518

87747

0.94

7.77

1.4

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

257

1002

1.48

7.77

5.0

6.5

24.9

25.1

mmol/l

0.40

237

908

(3012565) Volume of 24 hour Urine

363

1512

1.39

7.70

2.3

2.1

1938.8

2003.0

0.50

322

1354

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.93

7.68

2.0

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

238

916

1.50

7.66

2.2

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

323

1321

1.42

7.62

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

384

1618

1.37

7.61

1.5

1.6

1.3

1.2

nmol/l

0.29

292

1286

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

1.9

2.4

mg/l

0.31

144

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

2.6

2.3

mg/l

0.14

148

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

1.8

1.9

mg/l

0.06

157

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

1.0

0.9

mg/l

0.04

144

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

1.2

1.3

mg/l

0.08

131

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

1.7

2.2

mg/l

0.56

162

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

2.1

1.8

mg/l

0.15

137

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

2.7

mg/l

0.01

154

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

229

2.05

7.60

1.6

4.3

3.8

mg/l

0.22

144

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

206

1789

0.66

7.54

1.7

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

286

1.92

7.52

1.4

73.1

70.7

0.29

237

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

571

2556

1.29

7.51

1.4

1.3

78.5

119.4

pmol/l

0.60

241

792

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2997

15552

1.12

7.48

3.5

3.1

48.9

49.4

u/ml

0.04

2888

15035

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

362

1516

1.38

7.46

1.2

1.1

29.0

24.2

u/l

0.62

263

1177

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1031

4946

1.21

7.36

1.2

2.9

3.7

u/ml

0.99

319

1731

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

306

1.87

7.27

1.3

95.3

287.8

u/l

0.65

223

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

618

2810

1.27

7.21

1.5

1.6

32.1

30.8

0.35

381

1783

(3036603) Volume of Urine

459

2006

1.33

7.20

1.6

1.7

1980.9

1930.4

0.18

101

466

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1446

7165

1.17

7.15

2.4

126.3

109.8

ug/min

0.56

835

4342

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

101

316

1.85

7.15

1.2

1.3

—

(3016228) CD19 cells/100 cells in Blood

290

1180

1.42

7.08

2.3

2.0

7.4

8.6

1.00

279

1157

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

678

3131

1.25

6.97

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

259

1036

1.45

6.94

1.8

2.5

1.0

1.1

ug/l

0.40

242

973

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

355

1502

1.37

6.91

1.4

1.3

4.0

4.8

umol/l

3.50

326

1377

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

254

1013

1.45

6.91

1.2

111.9

111.3

0.13

226

906

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

213

820

1.50

6.90

1.5

1.6

9.9

8.9

ug/l

2.18

213

820

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

940

4500

1.21

6.89

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

206

789

1.51

6.84

1.3

3.7

3.5

mmol/l

0.38

188

729

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

311

1.82

6.67

2.1

2.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

151

542

1.61

6.65

2.4

2.5

7.0

7.6

mmol/l

1.07

101

315

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

399

1734

1.33

6.56

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

374

1610

1.34

6.55

1.5

8.7

7.9

ug/l

0.26

342

1456

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

142

504

1.63

6.55

2.1

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

453

2007

1.31

6.51

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

174

650

1.55

6.50

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

439

1938

1.31

6.47

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

128

444

1.67

6.45

1.1

2.7

8.2

pmol/l

0.70

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

994

4817

1.20

6.44

1.3

1.2

3.2

4.0

u/ml

1.95

414

2157

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

992

4807

1.20

6.43

1.1

11.3

11.2

au/ml

0.01

316

(3039443) Prostate specific Ag panel - Serum or Plasma

886

6139

0.83

6.40

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

281

1160

1.40

6.38

2.2

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

200

776

1.49

6.29

1.7

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

115

391

1.70

6.25

1.4

112639.0

267291.1

nmol/l

0.69

324

(3038177) Helicobacter pylori Ab [Presence] in Serum

1067

5221

1.18

6.21

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

199

1671

0.69

6.21

1.3

1.4

31.1

30.8

nmol/l

0.04

173

1520

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

483

2175

1.29

6.17

1.4

12.2

umol/l

0.04

452

2073

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

243

984

1.43

6.16

1.1

91.5

0.00

119

467

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

738

3491

1.22

6.16

1.2

1.1

1.4

2.0

iu/ml

0.42

(3017461) Flecainide [Moles/volume] in Serum or Plasma

146

2.18

6.12

1.5

1.7

0.7

umol/l

0.30

117

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

274

1135

1.40

6.12

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

290

1214

1.38

6.09

1.1

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

154

2.14

6.08

1.1

1.2

u/field

0.93

104

(3000330) Specific gravity of Urine by Test strip

2739

14323

1.11

6.01

3.8

3.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

229

922

1.44

6.00

3.2

3.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

316

1346

1.36

5.97

2.1

115.2

101.6

ug/min

0.14

307

(3002619) Bacteria identified in Specimen by Culture

155

578

1.55

5.88

1.3

1.2

—

(4212803)

220

1.92

5.86

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

574

1.55

5.86

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

123

434

1.64

5.86

1.4

1.3

0.2

0.3

nmol/l

0.89

297

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

264

1097

1.39

5.82

1.2

0.3

g/l

2.06

202

872

(3032352) Blasts [#/volume] in Cerebral spinal fluid

296

1.78

5.79

1.7

2.5

—

(44813793)

478

2169

1.28

5.78

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

190

744

1.48

5.76

1.8

2.0

40.2

38.7

u/l

0.04

171

671

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

186

726

1.48

5.73

1.3

39.1

38.9

0.02

131

486

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

132

478

1.60

5.69

1.3

1.4

110.6

274.4

ng/l

0.44

312

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

295

1.76

5.60

2.6

3.1

1.1

1.3

mg/l

0.48

201

(3004616) Nuclear Ab [Presence] in Serum

776

3730

1.21

5.56

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

858

0.59

5.55

2.5

2.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

151

568

1.54

5.54

4.3

6.2

66.2

71.5

1.52

120

449

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

973

4774

1.18

5.54

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

247

1025

1.39

5.51

1.2

1.1

108.1

108.2

0.02

222

934

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

598

2806

1.23

5.45

4.2

4.9

71.4

114.4

u/ml

1.61

156

889

(3047007) Chlamydophila sp Ab [Presence] in Serum

927

4538

1.18

5.43

1.3

1.2

—

(4306422)

976

4802

1.18

5.39

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

161

619

1.50

5.37

2.4

2.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

329

1436

1.33

5.35

1.4

1.5

4.6

3.7

0.33

334

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

128

468

1.58

5.33

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

140

2.11

5.29

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

943

4635

1.18

5.29

1.1

118.6

118.3

0.10

844

4220

(3024869) Neuronal Ab [Presence] in Serum

136

506

1.55

5.27

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

219

898

1.41

5.26

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

243

1015

1.39

5.25

1.1

89.1

90.8

0.29

115

481

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

164

637

1.49

5.22

1.5

0.4

ug/l

0.96

109

412

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

115

412

1.61

5.21

2.2

2.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

467

2144

1.26

5.19

3.1

2.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

122

445

1.59

5.15

5.3

5.0

55.1

44.6

ug/min

0.85

349

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

115

2.21

5.14

11.2

8.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

313

1.70

5.08

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

173

685

1.46

5.03

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

180

721

1.44

4.94

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3677

19695

1.08

4.88

2.1

1.9

—

(3042733) HLA Ab [Presence] in Serum

256

1093

1.36

4.87

5.2

5.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

772

1.42

4.84

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1499

7676

1.13

4.82

1.8

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

189

768

1.42

4.81

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

454

2098

1.25

4.81

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

574

2723

1.22

4.78

1.3

—

(3048879) Bone marrow aspiration report

192

784

1.42

4.77

1.8

—

(3001556) Androgen free Index in Serum or Plasma

281

1.71

4.69

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

104

374

1.61

4.69

1.3

1.2

1.1

1.3

mmol/l

0.09

239

(3024263) Appearance of Synovial fluid

340

1522

1.29

4.67

1.6

1.8

—

(3025315) Body weight

247

1.76

4.67

4.6

4.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

189

773

1.41

4.66

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

509

0.52

4.64

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

111

407

1.58

4.63

3.7

2.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

119

445

1.55

4.57

1.0

79.8

82.2

ug/l

0.24

364

(3002621) Streptococcal DNAse B [Units/volume] in Serum

253

1.74

4.57

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

186

762

1.41

4.56

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

243

1041

1.35

4.55

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

110

969

0.66

4.53

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

384

1.58

4.45

1.0

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

137

533

1.49

4.40

4.6

5.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

361

1644

1.27

4.37

1.1

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

261

1.71

4.37

1.1

24.0

19.5

u/l

0.85

165

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

703

3434

1.19

4.33

1.1

98.6

95.8

1.80

647

3230

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

573

1.46

4.32

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

207

1.79

4.26

3.7

2.7

86.4

73.8

pmol/l

0.07

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

178

1.85

4.24

1.5

1.3

15.8

17.1

pmol/l

0.22

151

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

342

1554

1.27

4.23

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

155

625

1.43

4.18

1.3

1.4

27.0

21.7

1.24

127

518

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

167

1.87

4.14

4.7

5.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1881

9856

1.11

4.10

1.3

209.2

221.2

miu/ml

0.66

720

4607

(3020393) Adenovirus Ag [Presence] in Stool

315

1.62

4.10

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

246

1.69

4.00

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

475

2256

1.22

3.99

2.0

1.7

7.2

6.7

mmol/l

2.78

362

1626

(3010370) Gastrin [Moles/volume] in Serum or Plasma

119

460

1.50

3.99

1.9

1.7

55.0

46.9

pmol/l

0.38

101

383

(3035285) Chloride [Moles/volume] in Venous blood

701

3455

1.17

3.93

2.7

2.3

105.3

105.8

mmol/l

1.53

695

3426

(3016750) Collection duration of Urine

376

1745

1.25

3.93

2.2

508.6

497.3

min

1.36

274

1307

(3000919) Neutrophils/100 leukocytes in Pleural fluid

171

711

1.39

3.92

1.4

22.1

22.8

0.12

152

648

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.57

3.90

1.8

2.6

1.5

2.4

mu/l

0.94

(3041354) Potassium [Moles/volume] in Venous blood

701

3458

1.17

3.89

2.7

2.3

4.1

mmol/l

0.10

695

3429

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

112

430

1.51

3.89

1.5

1.6

—

(3003129) Base excess in Capillary blood by calculation

168

701

1.39

3.78

1.8

1.6

0.7

0.4

mmol/l

0.38

159

658

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

850

4270

1.15

3.74

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

186

792

1.36

3.71

1.4

3.7

2.6

0.87

159

664

(3034274) Bile acid [Moles/volume] in Serum --fasting

581

3959

0.85

3.67

1.8

2.1

7.1

7.4

umol/l

0.17

426

2855

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

222

1.69

3.65

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

209

1.72

3.65

3.8

2.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

162

679

1.38

3.58

1.2

410.4

298.2

pmol/l

0.55

115

513

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

323

1.56

3.54

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

314

1447

1.26

3.54

1.7

1.9

146.2

142.7

0.35

290

1367

(3001686) Cold agglutinin [Titer] in Serum or Plasma

124

498

1.44

3.49

1.2

1.3

114.9

174.1

titre

0.37

(3006442) Creatine [Moles/volume] in Serum or Plasma

453

2175

1.21

3.47

1.7

1.5

69.8

69.6

umol/l

0.03

182

(3019897) Erythrocyte distribution width [Ratio] by Automated count

708

4728

0.86

3.47

3.4

2.4

13.2

0.74

699

4664

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

330

1.54

3.45

2.1

2.6

1.2

mmol/l

0.07

228

(3009015) Lactate [Moles/volume] in Synovial fluid

280

1.59

3.43

1.2

1.3

5.4

6.4

mmol/l

0.94

150

(3024471) HLA-A [Type]

245

1100

1.29

3.42

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

317

1.55

3.41

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.28

3.35

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

167

1.77

3.34

1.1

52.0

88.1

u/l

0.45

132

(3024932) HLA-DR beta [Type]

239

1075

1.29

3.31

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

169

725

1.35

3.27

1.2

1.3

241.8

272.6

ug/l

0.07

387

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

172

740

1.34

3.27

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.03

3.25

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

346

1630

1.23

3.24

1.8

1.7

2.7

2.4

u/field

0.42

266

1160

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

100

392

1.48

3.22

2.2

2.7

57.5

75.9

pmol/l

0.93

347

(21494567) Legionella sp IgM Ab [Presence] in Serum

200

1.68

3.20

1.2

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

202

893

1.31

3.20

1.4

55.3

54.2

0.15

167

778

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

197

1.67

3.13

7.8

4.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

151

642

1.36

3.11

1.2

89.0

89.3

0.02

180

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

307

1435

1.24

3.11

1.1

5.6

9.1

u/ml

1.28

254

(3032743) Legionella sp IgG Ab [Presence] in Serum

193

1.68

3.10

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

166

717

1.34

3.10

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

185

1.69

3.06

1.4

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

190

839

1.31

3.05

1.3

1.2

39.1

40.2

g/l

0.48

469

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

150

640

1.36

3.04

1.2

83.7

75.0

0.85

172

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

156

670

1.35

3.03

1.1

1.3

111.0

107.1

0.73

150

632

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

264

1219

1.25

2.99

1.1

602.0

454.0

ng/l

0.17

281

(3013247) Albumin in CSF/Albumin in Serum or Plasma

158

682

1.34

2.98

1.1

7.1

6.9

mg/g

0.11

147

648

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

412

1995

1.20

2.95

1.1

8.3

8.4

iu/ml

0.03

105

508

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

264

1.56

2.94

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

233

1063

1.27

2.93

1.7

2.0

176.8

165.0

0.75

223

1000

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

378

1.45

2.88

1.7

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

140

598

1.35

2.84

1.2

1.3

65.8

68.4

mu/l

0.06

100

455

(3038026) Centromere Ab [Units/volume] in Serum

492

2432

1.17

2.80

1.2

57.2

53.4

u/ml

0.07

110

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

157

1188

0.76

2.78

1.1

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

204

1.62

2.78

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

236

1.57

2.77

2.5

2.2

62.7

58.4

0.40

140

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

182

1350

0.78

2.76

1.1

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

316

1.48

2.73

2.5

2.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

188

1.63

2.69

1.2

1.4

—

(3049233) Organic acids panel - Urine

2.57

2.66

1.4

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

290

1.50

2.65

1.2

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.27

2.60

1.3

51.9

44.9

e6/l

0.09

(3033705) Calcium.ionized [Moles/volume] in Venous blood

671

3414

1.14

2.60

2.8

2.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

222

1.56

2.58

1.2

17.2

14.4

nmol/l

0.89

(3044416) Complement C4 [Mass/volume] in Pleural fluid

116

1.79

2.56

1.1

1.3

0.1

g/l

1.39

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

1.79

2.56

1.1

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

207

949

1.26

2.56

1.4

61.0

61.5

0.07

172

776

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

379

1849

1.19

2.56

5.9

6.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

474

2356

1.16

2.55

2.1

1.9

2.0

2.3

u/field

0.53

226

1017

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.95

2.54

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

308

1476

1.21

2.53

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

477

2376

1.16

2.50

1.2

73.9

68.6

u/ml

0.14

105

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

157

697

1.30

2.50

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

252

1.51

2.49

1.1

—

(3024316) Viscosity of Plasma

139

1.71

2.48

1.6

1.8

1.6

1.7

mpas

0.27

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

211

1.56

2.46

1.3

1.2

102.4

106.0

ug/l

0.07

135

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.01

2.46

1.4

1.1

520.7

319.7

pmol/l

0.32

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

216

1.55

2.45

1.1

9.4

10.0

u/l

0.12

216

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

294

1408

1.21

2.44

1.1

1592.0

1518.3

miu/ml

0.50

294

1408

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

127

549

1.34

2.44

1.4

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

477

2382

1.16

2.43

1.2

49.2

46.2

u/ml

0.09

173

(3008898) HLA-B27 [Presence]

2046

11038

1.07

2.43

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

198

1.58

2.43

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1883

11689

0.93

2.43

1.8

1.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

123

530

1.34

2.42

3.1

5.1

49.3

59.0

u/l

0.42

212

(40762814) Titanium [Mass/volume] in Blood

108

456

1.37

2.42

2.1

2.3

3.5

3.8

ug/l

0.32

160

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

458

2282

1.16

2.41

1.2

3.3

8.8

u/ml

1.71

155

(4268621)

642

3277

1.13

2.40

2.4

2.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

106

447

1.37

2.39

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

413

1.39

2.38

1.1

0.3

u/ml

0.01

261

(44786800) Granulocytes/100 leukocytes in Body fluid

326

1.44

2.38

1.3

23.3

25.4

0.23

247

(42529582) MDA5 Ab [Presence] in Serum by Line blot

161

723

1.29

2.38

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

161

723

1.29

2.38

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

161

723

1.29

2.38

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

161

723

1.29

2.38

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

288

1.47

2.37

1.1

1.7

3.0

umol/24h

0.51

288

(43055442) Apixaban [Mass/volume] in Serum or Plasma

331

1.43

2.37

1.6

113.6

111.2

ug/l

0.06

272

(44806071)

100

419

1.38

2.35

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8912

49975

1.04

2.34

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

337

1.42

2.33

1.5

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

280

1.47

2.32

1.1

—

(3025130) Human papilloma virus identified in Specimen

850

4426

1.11

2.28

1.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

188

1.57

2.27

1.6

1.8

1.0

0.6

0.46

144

(3051387) C reactive protein [Mass/volume] in Capillary blood

1205

6386

1.09

2.26

4.2

3.1

26.3

26.8

mg/l

0.15

736

4029

(40763480) Human metapneumovirus Ag [Presence] in Specimen

130

1.69

2.25

1.3

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

403

1.38

2.25

1.7

1.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

231

1.50

2.22

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

231

1094

1.22

2.19

2.0

1.9

8.7

9.3

mg/l

0.92

180

880

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

122

535

1.32

2.17

2.3

1.8

—

(3006598) pH of Arterial cord blood

141

0.41

2.16

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

3.25

2.15

2.7

1.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.93

2.15

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.11

2.14

1.2

1.1

93.5

97.1

nmol/24h

0.07

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.99

2.14

1.1

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.02

2.13

2.5

2.8

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

2.13

0.0

1.1

—

70.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

164

1.59

2.12

1.4

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

189

880

1.24

2.11

1.7

1.6

102.8

134.7

au/ml

0.46

111

(3014148) Varicella zoster virus Ab [Titer] in Serum

782

4074

1.11

2.11

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

580

3776

0.89

2.10

1.0

0.5

u/ml

0.02

127

809

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

370

1.38

2.07

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

10306

58056

1.03

2.07

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

341

1.39

2.06

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.89

2.05

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

218

1035

1.22

2.04

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.75

2.03

1.0

1.1

138.2

226.0

pmol/l

1.25

(40768795) Lymph node Pathology biopsy report

565

2898

1.13

2.02

1.3

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.77

2.01

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

424

2135

1.15

2.00

2.0

1.7

—

(3007147) Virus identified in Stool by Electron microscopy

3.30

1.99

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

167

1.56

1.99

1.0

1.1

1.4

3.3

u/l

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.96

1.98

1.0

0.3

0.6

u/ml

0.45

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.81

1.96

1.2

1.3

—

(3007461) Platelets [#/volume] in Blood

60474

348436

1.04

1.95

28.2

18.6

253.5

252.1

e9/l

5.91

59234

339594

(3008037) Lactate [Moles/volume] in Venous blood

1171

6246

1.09

1.95

3.8

3.0

1.6

mmol/l

0.22

1142

6122

(3041806) Other cells [#/volume] in Blood by Manual count

119

883

0.78

1.93

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

114

1.67

1.93

1.2

1.4

1.2

1.0

u/field

0.64

(3037556) Urate [Mass/volume] in Serum or Plasma

177

829

1.23

1.91

1.6

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

249

1.44

1.91

1.2

1.3

1.2

1.5

ml/s/173m2

0.39

163

(1617658) Protocol used for examination of sentinel lymph nodes

421

2129

1.14

1.89

1.0

—

(3004775) Volume in Urine collected for unspecified duration

468

2384

1.14

1.89

2.2

2.3

733.9

670.0

2.13

333

1628

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36313

207935

1.02

1.89

3.2

3.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

111

0.42

1.88

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

184

1.51

1.86

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

107

473

1.31

1.85

1.1

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

932

4936

1.09

1.85

1.1

10957.1

936.5

iu/ml

0.44

202

1075

(3013931) Oligosaccharides [Presence] in Urine

4.82

1.83

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

364

1.35

1.83

2.4

2.5

0.6

u/field

0.01

364

(3010726) Horse dander IgE Ab [Units/volume] in Serum

854

5392

0.91

1.78

1.1

1.3

2.1

u/ml

1.63

207

1297

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.70

1.76

1.0

1.1

1960.4

4284.0

ng/l

—

(3009677) Dengue virus Ab [Presence] in Serum

113

1.64

1.75

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

110

493

1.29

1.74

1.4

—

(3022689) Creatine [Moles/volume] in Urine

176

835

1.22

1.72

1.5

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.45

1.71

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1355

7312

1.07

1.71

4.7

3.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

642

3355

1.11

1.71

1.2

—

(3020650) Glucose [Presence] in Urine

172

816

1.22

1.69

1.6

1.4

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.76

1.68

4.1

6.6

0.8

1.5

mg/l

2.15

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

133

614

1.25

1.68

1.2

0.9

50.7

mg/l

2.43

108

438

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

247

1213

1.18

1.68

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

532

0.74

1.67

5.0

5.6

—

(3051339) Copper [Moles/volume] in Blood

156

1.52

1.67

1.1

1.2

17.2

16.7

umol/l

0.33

136

(3001729) Color of Synovial fluid

223

1.43

1.65

1.5

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

180

1.48

1.65

2.0

2.2

—

(3034426) Prothrombin time (PT)

222

1082

1.19

1.65

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

397

1.31

1.62

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

302

2010

0.87

1.62

1.0

1.1

2.3

2.2

u/ml

0.03

490

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

263

1.39

1.62

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

153

1.51

1.60

3.7

3.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

393

1.31

1.60

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1289

6965

1.07

1.59

1.4

132.5

127.6

pmol/l

0.13

1254

6805

(3015076) Soybean IgE Ab [Units/volume] in Serum

269

1802

0.86

1.59

1.0

0.3

0.8

u/ml

0.89

242

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

177

1.47

1.59

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

126

1.56

1.57

1.2

1.1

0.5

umol/24h

0.51

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

175

0.56

1.56

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

315

1.34

1.54

1.4

1.6

148.9

174.5

mmol/l

1.22

280

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

711

4490

0.91

1.54

1.2

1.3

7.3

7.1

mmol/l

0.62

509

3259

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

244

1641

0.86

1.53

1.3

—

(40765096) Chromosome analysis panel by Banding

168

805

1.21

1.53

1.2

—

(3000285) Sodium [Moles/volume] in Blood

341

1.32

1.52

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

147

696

1.22

1.51

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate

260

1737

0.86

1.50

1.3

1.2

—

(3041184) Isoniazid [Presence] in Urine

2.17

1.48

2.8

2.7

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.70

1.47

1.0

1.1

24.7

32.0

umol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

190

1.43

1.46

1.3

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

404

1.29

1.46

1.5

1.4

11.0

12.0

0.13

208

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.72

1.46

9.5

8.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.80

1.46

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

339

1.31

1.44

2.1

1.6

1.7

mg/l

0.04

286

(3013945) Hepatitis B virus e Ab [Presence] in Serum

186

1.43

1.44

1.2

1.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

191

1.42

1.43

2.4

2.3

16.7

15.1

0.11

(3003338) MCHC [Mass/volume]

46396

269754

0.98

1.42

24.8

16.0

332.4

332.7

g/l

14.03

46060

267683

(4281824)

591

3112

1.10

1.41

1.2

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

146

697

1.21

1.40

1.3

1.2

509.1

507.9

titre

0.00

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.93

1.40

1.1

1.0

—

(3035941) MCH [Entitic mass]

60483

348717

1.03

1.39

28.0

18.5

30.4

30.3

113.68

59728

344145

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

142

678

1.21

1.37

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

150

1.46

1.35

1.5

1.7

212.7

190.2

ng/l

0.68

128

(3024731) MCV [Entitic volume]

60488

348763

1.03

1.35

28.1

18.5

91.4

90.7

238.63

59728

344180

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

672

3569

1.09

1.35

2.4

2.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

338

1.30

1.35

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

118

554

1.23

1.35

2.6

1.7

6.0

2.9

ug/l

0.33

338

(3026361) Erythrocytes [#/volume] in Blood

60491

348791

1.03

1.33

28.2

18.6

4.4

4.5

e12/l

307.65

59108

338991

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.69

1.33

1.3

1.7

180.4

110.4

ug/l

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.69

1.33

9.9

8.0

43.9

0.00

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

463

1.25

1.30

2.8

2413.3

1624.0

u/l

0.40

414

(3038515) Glucose [Moles/volume] in Venous blood

1088

5897

1.07

1.29

4.0

3.1

7.4

7.6

mmol/l

1.45

1063

5793

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

417

1.26

1.29

1.1

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

417

1.26

1.29

2.3

2.5

—

(3014891) Appearance of Pleural fluid

361

1.28

1.6

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

181

1.41

1.28

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

698

4366

0.92

1.26

1.1

3.7

4.5

u/ml

0.51

286

1768

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

429

1.25

1.26

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

261

1.33

1.26

1.0

1.1

2.9

5.4

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

424

1.25

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2994

17962

0.96

1.25

1.8

1.6

—

(3020618) Glucose [Moles/volume] in Synovial fluid

101

1.55

1.24

1.0

1.1

5.7

5.2

mmol/l

0.22

(3043614) Bacteria identified in Aspirate by Culture

2.89

1.24

1.2

1.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.65

1.19

1.2

1.1

0.5

0.0

g/l

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

220

1107

1.15

1.19

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

199

994

1.16

1.19

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.84

1.17

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

112

1.50

1.17

1.2

1.5

—

(3010813) Leukocytes [#/volume] in Blood

60491

348867

1.03

1.17

28.2

18.6

6.9

6.7

e9/l

66.11

59117

339036

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.53

1.17

1.0

1.3

17.3

36.7

nmol/24h

—

(3000963) Hemoglobin [Mass/volume] in Blood

60496

348902

1.03

1.16

28.3

18.7

134.3

136.4

g/l

220.99

59755

344330

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

270

1.31

1.16

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

396

0.76

1.15

2.2

1.8

7.5

7.4

mmol/l

0.07

139

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.59

1.15

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

150

735

1.18

1.15

8.4

8.8

—

(3027874) Urate [Moles/volume] in Urine

1.54

1.14

1.1

1.4

8.4

mmol/l

0.54

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

363

1.26

1.13

2.2

1.2

9.5

63.9

u/ml

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

172

1.38

1.10

1.2

1.3

542.4

1120.3

u/l

0.46

151

(4034850)

1668

10097

0.95

1.10

12.5

8.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

293

1514

1.12

1.08

1.2

1.1

11.0

14.0

u/ml

0.15

152

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

376

1.25

1.08

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

746

4617

0.93

1.07

1.1

3.4

4.4

u/ml

0.74

285

1782

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

248

1270

1.13

1.06

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

380

1994

1.10

1.06

1.2

1.1

ratio

0.26

139

698

(3018133) Calcium [Moles/volume] in Urine

466

1.22

1.05

2.1

1.9

2.5

2.7

mmol/l

0.48

416

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.00

1.05

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

102

488

1.21

1.04

1.2

1.1

—

(36304079) Mucus [Presence] in Urine sediment

2.41

1.03

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

316

2024

0.90

1.02

1.0

1.1

2.7

1.4

u/ml

0.24

560

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.39

1.02

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

669

0.83

1.02

2.7

100.3

105.9

ng/l

0.12

332

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

1.01

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

176

885

1.15

1.00

2.5

1.7

—

(3007542) Rye IgE Ab [Units/volume] in Serum

167

0.66

1.00

1.0

0.7

12.1

u/ml

0.47

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

112

1.45

0.99

1.2

1.1

2.1

1.0

u/field

0.44

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

277

1436

1.12

0.99

1.1

96.3

98.3

0.52

221

1154

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

166

1.36

0.99

1.0

0.8

0.3

u/ml

0.49

151

(3038071) Oxygen [Partial pressure] in Mixed venous blood

131

645

1.17

0.98

8.7

8.8

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.48

0.98

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.48

0.98

1.2

1.1

—

(3032641) Amino acids panel - Urine

1.86

0.98

1.3

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

947

5785

0.95

0.93

1.1

4.2

4.8

u/ml

0.72

459

2942

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

426

1.21

0.93

1.4

1.3

60.2

50.4

1.02

199

(3008401) Mugwort IgE Ab [Units/volume] in Serum

901

5510

0.94

0.92

1.1

0.8

1.1

u/ml

1.22

360

2288

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.59

0.91

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

174

1.33

0.90

1.2

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

169

1.33

0.90

1.1

1.4

1.2

1.6

0.28

105

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

266

1704

0.90

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

328

1.23

0.90

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

105

1.43

0.89

1.0

1.2

230.1

276.7

nmol/l

0.85

105

(3006969) Lambda light chains [Mass/volume] in Urine

1.55

0.89

1.1

0.0

0.1

g/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1052

6396

0.95

0.88

1.1

1.4

1.5

u/ml

0.08

414

2557

(3022475) Manganese [Moles/volume] in Blood

190

1.31

0.88

1.1

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

150

1.35

0.87

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.61

0.85

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

141

1.35

0.84

1.6

1.5

0.2

0.1

u/l

—

(4211845)

295

1553

1.10

0.83

3.0

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1070

5895

1.05

0.83

1.7

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

850

4657

1.06

0.82

1.1

2.8

3.0

u/ml

0.15

340

2361

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.93

0.82

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

147

1.34

0.81

1.1

1.0

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.58

0.80

1.3

1.4

0.7

0.6

u/field

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

113

1.38

0.79

2.2

1.3

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.72

0.79

1.0

1.1

—

(44806420)

149

758

1.14

0.78

2.1

2.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

277

1.23

0.77

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

174

1.30

0.77

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.22

0.77

1.0

1.1

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.22

0.77

1.0

1.2

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.22

0.77

1.0

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

154

1.31

0.76

11.8

9.6

200.7

313.2

e6/l

0.35

113

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.75

0.76

1.1

1.0

—

(3009992) Blasts/100 cells in Bone marrow

1.93

0.76

1.7

1.8

16.9

18.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

581

3569

0.94

0.74

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.84

0.74

1.0

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

120

1.35

0.73

1.3

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

213

1114

1.11

0.72

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

477

1.16

0.71

5.9

7.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

194

0.74

0.71

1.2

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.52

0.71

1.0

489.0

335.4

umol/l

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

0.71

0.70

1.0

0.1

10.3

u/ml

0.52

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

126

1.33

0.70

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.93

0.69

1.0

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

198

1.26

0.69

1.4

1.5

10.4

14.2

0.64

135

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.69

0.68

1.1

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.53

0.67

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

1.63

0.67

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

178

1.27

0.67

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

132

1.31

0.67

1.2

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

172

0.74

0.67

1.0

1.1

5.7

6.7

u/ml

0.15

122

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

107

540

1.15

0.66

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

268

1426

1.09

0.65

2.0

2.2

19.0

215.0

ug/l

1.85

252

1363

(3032868) Hemoglobin electrophoresis panel in Blood

281

0.80

0.65

1.5

1.6

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

226

1.23

0.64

1.4

1.1

2.1

25.5

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.71

0.64

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.53

0.64

1.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.53

0.64

1.0

1.1

—

(4038314)

216

0.78

0.63

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

418

0.84

0.62

14.2

6.7

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

0.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.38

0.60

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.50

0.60

3.2

4.4

—

(3011897) Casein IgE Ab [Units/volume] in Serum

486

1.14

0.59

1.1

1.2

6.6

2.4

u/ml

0.27

108

(3022670) pH of Venous cord blood

0.56

0.58

1.0

1.1

—

(4133840)

146

936

0.90

0.58

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

223

1401

0.92

0.58

1.7

1.8

—

(37019676) Renin [Units/volume] in Plasma --supine

1.42

0.58

1.1

28.2

63.2

mu/l

0.73

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

389

2117

1.06

0.55

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.42

0.54

1.3

1.0

1.9

2.7

1.05

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.34

0.54

2.6

3.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

181

959

1.09

0.52

1.1

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

219

1170

1.08

0.52

2.9

3.2

8.9

7.8

mg/l

0.99

168

933

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

102

1.30

0.52

1.7

2.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

512

2815

1.05

0.51

1.3

12.2

11.8

mmol/l

0.51

188

704

(3020123) Porphyrins [Interpretation] in Serum or Plasma

180

1.22

0.51

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

154

1.24

0.51

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

212

1.20

0.51

2.3

—

(3013862) HLA-DP [Type]

118

1.27

0.50

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

256

1.17

0.48

1.1

18.1

17.1

g/l

0.39

230

(3006462) Nitrate [Presence] in Urine

264

1427

1.07

0.48

3.1

3.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.60

0.47

1.0

1.1

1016.0

2210.6

titre

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

174

0.80

0.46

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

147

926

0.92

0.45

1.0

12.1

9.5

u/ml

0.30

131

(3027035) Albumin [Mass/time] in 24 hour Urine

296

1.15

0.45

1.5

1.3

234.9

362.3

mg/24h

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.39

0.44

1.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.39

0.44

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

210

0.83

0.43

1.1

1.3

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.43

0.0

1.2

—

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

191

0.82

0.43

1.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.40

0.42

2.4

2.3

—

(40763590) HLA-DQ beta [Type]

116

1.25

0.42

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

222

0.83

0.42

1.0

0.1

1.0

u/ml

0.62

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2088

11826

1.02

0.41

2.3

2.2

4655.0

5487.6

u/l

0.58

661

4719

(3015350) Toxocara sp Ab [Presence] in Serum

1.36

0.41

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

200

1080

1.07

0.40

2.4

2.7

117.9

159.1

au/ml

0.73

146

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

229

1.16

0.40

1.4

1.5

38.1

37.6

0.03

145

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

404

1.12

0.39

1.0

—

(40768800) Prostate Pathology biopsy report

1028

5779

1.03

0.38

1.2

—

(40760410) HLA-B [Type] by High resolution

118

1.22

0.38

1.0

—

(40760409) HLA-A [Type] by High resolution

118

1.22

0.38

1.0

—

(46236302) HLA-C [Type] by High resolution typing

118

1.22

0.38

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.25

0.38

1.7

2.7

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.33

0.37

1.6

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.34

0.37

2.0

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

280

1.14

0.36

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.70

0.36

2.0

2.5

8.2

28.1

nmol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

354

1955

1.05

0.35

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

142

883

0.93

0.35

1.1

1.3

6.8

u/ml

0.80

486

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

170

919

1.07

0.35

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.39

0.35

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.39

0.35

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

303

1.13

0.35

2.6

2.4

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

141

1.19

0.34

1.7

2.3

2.8

11.8

nmol/l

1.56

133

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.23

0.31

1.1

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.69

0.31

1.1

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

137

1.18

0.31

19.2

14.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

196

0.86

0.31

1.1

1.0

0.1

0.6

u/ml

2.57

109

(3013466) aPTT in Blood by Coagulation assay

192

1.14

0.30

1.2

1.1

35.7

36.7

0.38

164

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

165

1.16

0.29

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

209

1.13

0.29

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

101

1.20

0.28

1.0

0.2

u/ml

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.28

0.28

1.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

139

1.16

0.28

1.0

0.1

u/ml

0.14

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

113

612

1.07

0.25

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

113

612

1.07

0.25

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.18

0.25

1.9

5.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

212

1.12

0.24

4.0

4.8

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

1.38

0.24

1.0

1.1

85.0

88.1

umol/l

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

147

1.14

0.23

1.4

1.3

1.9

1.6

mg/l

0.43

123

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

162

983

0.95

0.22

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.9

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.21

0.0

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.78

0.20

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.20

0.20

1.2

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

111

1.15

0.19

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

181

0.89

0.19

3.8

2.9

19.3

14.0

0.61

(3011841) English Walnut IgE Ab [Units/volume] in Serum

289

0.92

0.18

1.0

1.1

0.4

2.1

u/ml

1.72

213

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1904

10885

1.01

0.18

1.4

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

128

1.13

0.18

1.0

0.1

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

111

612

1.05

0.17

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

501

0.95

0.16

1.1

0.5

4.0

u/ml

2.02

357

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.13

0.16

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.13

0.16

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.13

0.16

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.13

0.16

1.9

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.13

0.16

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.13

0.16

1.0

—

(3003577) Lead [Moles/volume] in Blood

257

0.92

0.16

1.3

1.5

0.2

umol/l

0.56

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

286

0.93

0.15

1.0

1.1

0.5

1.7

u/ml

0.44

160

(3049242) von Willebrand panel - Platelet poor plasma

1.12

0.12

1.2

1.7

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.87

0.11

3.6

5.7

0.3

mmol/l

0.09

(3012989) Citrate [Moles/time] in 24 hour Urine

1.14

0.10

1.2

1.6

1.8

2.1

mmol/24h

0.50

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

393

0.96

0.10

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

257

0.94

0.10

3.1

2.4

844.1

290.2

umol/l

0.79

248

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.16

0.10

1.0

4.0

—

(3034614) HLA Ag [Interpretation]

1.12

0.09

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

332

1.04

0.09

1.1

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.10

0.09

1.1

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

297

0.95

0.09

1.0

0.4

0.1

u/ml

0.62

177

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

168

1.07

0.09

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.12

0.08

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.06

0.08

1.4

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.85

0.08

1.2

1.0

147.2

142.6

mmol/24h

—

(3019174) dRVVT (LA screen)

294

1.04

0.08

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

218

1281

0.98

0.07

1.8

1.9

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.04

0.07

1.1

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

438

1.03

0.06

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

368

2151

0.99

0.06

1.3

1.4

1.5

g/l

0.65

115

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.12

0.06

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

276

0.96

0.06

1.0

1.1

0.1

0.7

u/ml

1.04

150

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.92

0.06

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

0.94

0.05

1.0

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

257

0.97

0.04

1.0

1.1

1.0

0.4

u/ml

0.33

143

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

302

1760

0.99

0.04

1.3

1.4

5.9

5.7

mmol/l

3.40

284

1662

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

126

720

1.01

0.03

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

185

1.03

0.02

1.0

0.2

1.6

u/ml

1.11

139

(3041672) Baker's yeast Ab [Presence] in Serum

150

0.96

0.02

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1814

10473

1.00

0.01

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

922

5322

1.00

0.01

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

279

1.02

0.01

1.0

1.1

0.3

2.1

u/ml

1.26

210

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

241

0.98

0.01

1.0

1.1

7.6

19.2

iu/ml

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

102

0.96

0.00

1.1

1.0

—

(40763791) Oxygen content in Venous blood by calculation

1.04

0.00

6.3

7.5

12.8

12.0

ml/dl

0.48

(3044009) aPTT.lupus sensitive (LA screen)

303

1.01

0.00

1.3

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

108

1.02

0.00

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.02

0.00

1.1

1.0

0.2

0.0

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

183

1.01

0.00

1.0

1.1

20.4

24.8

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

183

1.01

0.00

1.0

1.1

60.6

24.4

u/ml

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

192

0.99

0.00

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

206

1.01

0.00

1.4

362.7

324.9

umol/24h

0.31

206

(3022229) Phosphate [Moles/volume] in Urine

142

0.98

0.00

1.8

2.3

16.8

18.6

mmol/l

0.24

117

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

261

1.00

0.00

1.3

22.9

20.9

mmol/l

1.75

201

(40758358) Immune stain study

132

1.01

0.00

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

921

5325

1.00

0.00

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.99

0.00

1.1

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.90

0.00

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.99

0.00

1.3

1.4

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.0

1.8

—

(3035109) Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.85

0.00

1.0

1.1

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.93

0.00

1.0

1.1

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_N05C and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_N05C	1.11 [1.04, 1.18]	0.001
Birth year	0.996 [0.99, 1.0]	0.3

During the follow-up period (1.1.1998 — 31.12.2019), 70922 out of 292693 females with RX_N05C died.

Males

Parameter	HR [95% CI]	p-value
RX_N05C	1.566 [1.46, 1.68]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 67683 out of 212291 males with RX_N05C died.

Mortality risk

Mortality risk for people of age

years, who have RX_N05C.

N-year risk	Females	Males
1	0.083%	0.214%
5	0.599%	1.512%
10	1.465%	4.079%
15	2.854%	7.63%
20	5.057%	12.536%

Relationships between endpoints

↥

Index endpoint: RX_N05C – Use of hypnotics and sedatives

GWS hits: 39

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Use of hypnotics and sedatives

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints